CN117338892A - Gel emplastrum for treating arthralgia and preparation method thereof - Google Patents
Gel emplastrum for treating arthralgia and preparation method thereof Download PDFInfo
- Publication number
- CN117338892A CN117338892A CN202311571585.8A CN202311571585A CN117338892A CN 117338892 A CN117338892 A CN 117338892A CN 202311571585 A CN202311571585 A CN 202311571585A CN 117338892 A CN117338892 A CN 117338892A
- Authority
- CN
- China
- Prior art keywords
- parts
- rhizoma
- phase
- gel
- patch
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
- A61K36/12—Filicopsida or Pteridopsida
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/254—Acanthopanax or Eleutherococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/26—Aristolochiaceae (Birthwort family), e.g. heartleaf
- A61K36/268—Asarum (wild ginger)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/902—Sparganiaceae (Bur-reed family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
发明领域:Field of the invention:
本发明涉及一种治疗痹痛的凝胶贴膏剂及其制备方法,属于药品的技术领域。The invention relates to a gel plaster for treating arthralgia and a preparation method thereof, belonging to the technical field of medicines.
背景技术Background Art
痹痛是一种常见的疾病,主要表现为痛风,痹痛是由于嗜好无度、肾气日衰、疏泄失调以及营养过剩等因素引起。从中医角度分析,痹痛与人的筋脉和气血相关,阳气亏虚则不能养筋,而致使纤维肌痛等。在《素问·痹论》中提到:“三气杂至,合而为痹”,“逆其气则痹,从其气则愈,不与风寒湿气合,故不为痹”,说明了痹症的发生与正气以及卫气的强弱有关,如果人体阳气亏虚,卫阳就不足,则抵御外邪功能将减弱,风寒湿邪会乘虚而入;另外若正气不足,驱邪外出的能力下降,风寒湿邪就滞留在肌肉筋骨中,经脉不通、气血不通,则形成痹痛。饮食不规律和劳累过度等都是发病的原因。痹痛由于个体差异,没有最好的治疗方法,但是可以通过中医理疗、外用药物、服用药物来进行治疗。Arthralgia is a common disease, mainly manifested as gout. Arthralgia is caused by excessive hobbies, declining kidney qi, disordered drainage and overnutrition. From the perspective of traditional Chinese medicine, arthralgia is related to the tendons and blood of the human body. If the yang qi is deficient, the tendons cannot be nourished, which leads to fibromyalgia and other diseases. In Suwen Bilun, it is mentioned that "the three qi are mixed and combined to form arthralgia", "if the qi is against, it will be arthralgia, if it is followed, it will be cured. If it does not combine with wind, cold and dampness, it will not be arthralgia", which shows that the occurrence of arthralgia is related to the strength of the positive qi and the defensive qi. If the human body's yang qi is deficient, the defensive yang will be insufficient, and the function of resisting external evil will be weakened, and the wind, cold and dampness will take advantage of the opportunity to enter; in addition, if the positive qi is insufficient, the ability to expel evil will decrease, and the wind, cold and dampness will be retained in the muscles, tendons and bones, and the meridians and qi and blood will be blocked, forming arthralgia. Irregular diet and excessive fatigue are all causes of the disease. Due to individual differences, there is no best treatment for arthralgia, but it can be treated through traditional Chinese medicine physiotherapy, external medications, and oral medications.
凝胶贴膏剂最早出现在德国,经过日本学者的研制以后,被称为定型巴布剂,巴布剂的水溶性基质保湿性好,对皮肤刺激小,生物利用度高,载药量大,比较适合用于像中药这种组分多、用量大的特点。凝胶贴膏有很多的优点。第一,因为是透皮制剂给药,给药方式上可以避免肝脏首过效应,减少对胃肠道的刺激。第二,可以避免口服引起血药浓度的波动。第三,可以延长给药时间,减少给要次数。第四,贴膏剂能够承载更多药量,容易贴合皮肤,而且刺激性小,使用起来方便。但是贴膏也存在的一定的不足,比如产品质量不稳定,用药量大,容易脱膏和漏膏等。Gel patches first appeared in Germany. After being developed by Japanese scholars, they were called stereotyped plasters. The water-soluble matrix of plasters has good moisturizing properties, little skin irritation, high bioavailability, and large drug loading capacity. They are more suitable for use in traditional Chinese medicines with many components and large dosages. Gel patches have many advantages. First, because it is a transdermal preparation, the administration method can avoid the first-pass effect of the liver and reduce irritation to the gastrointestinal tract. Second, it can avoid fluctuations in blood drug concentration caused by oral administration. Third, it can extend the administration time and reduce the number of administrations. Fourth, the plaster can carry more drugs, is easy to fit the skin, and is less irritating and easy to use. However, there are certain shortcomings in the plaster, such as unstable product quality, large dosage, easy to remove the plaster and leak the plaster, etc.
本发明通过正交试验法做提取工艺和寻找基质配方便捷、可靠,最优基质处方下贴膏有较好的黏性和成型性,高效液相法检测基质含量,质量标准稳定,复方痹痛贴膏剂制备工艺可行,且痹痛方具有良好的祛风除湿、强筋健骨、化瘀止痛的作用,达到课题设计的预期目的。The invention uses an orthogonal test method to perform an extraction process and find a matrix formula, which is convenient and reliable. The plaster has good viscosity and formability under the optimal matrix formula. The matrix content is detected by high performance liquid chromatography, and the quality standard is stable. The preparation process of the compound bitong plaster is feasible, and the bitong formula has good effects of dispelling wind and dampness, strengthening tendons and bones, and removing blood stasis and relieving pain, thereby achieving the expected purpose of the subject design.
发明内容Summary of the invention
本发明所要解决的技术问题在于提供一种治疗痹痛的凝胶贴膏剂及其制备方法。本发明具有祛风除湿、强筋健骨、化瘀止痛的功效的凝胶贴膏剂,用于治疗风湿痹痛,适用于风湿痹痛人群。易于制备操作,制得的贴膏有较好的黏性和成型性,产品质量较好。The technical problem to be solved by the present invention is to provide a gel plaster for treating arthralgia and a preparation method thereof. The gel plaster of the present invention has the effects of dispelling wind and dampness, strengthening tendons and bones, and removing blood stasis and relieving pain, and is used for treating rheumatic arthralgia and is suitable for people with rheumatic arthralgia. The preparation operation is easy, and the prepared plaster has good viscosity and formability, and the product quality is good.
为解决以上技术问题,本发明采用以下技术方案实现:In order to solve the above technical problems, the present invention adopts the following technical solutions:
一种治疗痹痛的凝胶贴膏剂,其药用有效成分按照重量组分计算:由制川乌90-150份、北细辛40-80份、苍术60-120份、独活60-120份、牛膝60-120份、全当归90-150份、穿山龙200-400份、千年健200-400份、追地风200-400份、威灵仙130-230份、松节100-200份、红禾麻100-200份、桑寄生90-150份、狗脊90-150份、五加皮90-150份、鸡血藤100-200份、三棱90-150份、莪术90-150份制成。A gel plaster for treating arthralgia. The medicinal active ingredients thereof are calculated by weight as follows: 90-150 parts of processed Chuanwu, 40-80 parts of northern asarum, 60-120 parts of atractylodes, 60-120 parts of angelica, 60-120 parts of angelica sinensis, 200-400 parts of rhizoma dicophora, 200-400 parts of rhizoma scutellariae, 200-400 parts of rhizoma scutellariae, 130-230 parts of clematis, 100-200 parts of pine knot, 100-200 parts of red hemp, 90-150 parts of parasitic plant, 90-150 parts of cibotium bark, 90-150 parts of cortex acanthopanacis, 100-200 parts of millettia reticulata, 90-150 parts of trillium and 90-150 parts of zedoaria.
前述的治疗痹痛的凝胶贴膏剂,其药用有效成分按照重量组分计算:由制川乌100-140份、北细辛50-70份、苍术70-110份、独活70-110份、牛膝70-110份、全当归100-140份、穿山龙250-350份、千年健250-350份、追地风250-350份、威灵仙150-210份、松节120-180份、红禾麻80-120份、桑寄生100-140份、狗脊100-140份、五加皮100-140份、鸡血藤120-180份、三棱100-140份、莪术100-140份制成。The above-mentioned gel patch for treating arthralgia, its medicinal active ingredients are calculated by weight: 100-140 parts of processed Chuanwu, 50-70 parts of northern asarum, 70-110 parts of atractylodes, 70-110 parts of Duhuo, 70-110 parts of Achyranthes bidentata, 100-140 parts of whole angelica, 250-350 parts of Rhizoma Dioscoreae, 250-350 parts of Rhizoma Dioscoreae, 250-350 parts of Radix Clematis, 120-180 parts of pine knot, 80-120 parts of red hemp, 100-140 parts of mistletoe, 100-140 parts of Cibotium bark, 100-140 parts of Acanthopanax, 120-180 parts of Millettia reticulata, 100-140 parts of Trillium, and 100-140 parts of Curcuma.
具体的说,前述的治疗痹痛的凝胶贴膏剂,其药用有效成分按照重量组分计算:由制川乌120份、北细辛60份、苍术90份、独活90份、牛膝90份、全当归120份、穿山龙300份、千年健300份、追地风300份、威灵仙180份、松节150份、红禾麻100份、桑寄生120份、狗脊120份、五加皮120份、鸡血藤150份、三棱120份、莪术120份制成。Specifically, the aforementioned gel patch for treating arthralgia, its medicinal active ingredients are calculated by weight: 120 parts of processed Chuanwu, 60 parts of northern asarum, 90 parts of atractylodes, 90 parts of Duhuo, 90 parts of Achyranthes, 120 parts of whole angelica, 300 parts of Rhizoma Cynoglossi, 300 parts of Rhizoma Cynoglossi, 300 parts of Rhizoma Cynoglossi, 180 parts of Clematidis, 150 parts of pine knot, 100 parts of red hemp, 120 parts of mistletoe, 120 parts of Cibotium bark, 120 parts of Acanthopanax, 150 parts of Millettia reticulata, 120 parts of Trillium, and 120 parts of Curcuma.
前述治疗痹痛的凝胶贴膏剂的制备方法,所述制备方法按照以下步骤进行:The preparation method of the aforementioned gel patch for treating arthralgia is carried out according to the following steps:
(1)按照处方比例称取药材,进行粉碎成粗,用电子分析天平精确称量药材总质量为15-20g,用12-18倍的乙醇进行浸泡18-30h,再回流提取2-4h,过滤,取滤液在60-80℃条件下进行干燥,得到中药药膏,备用;(1) Weighing the medicinal materials according to the prescription ratio, crushing them into coarse powder, accurately weighing the total mass of the medicinal materials to 15-20 g using an electronic analytical balance, soaking them in 12-18 times ethanol for 18-30 hours, refluxing and extracting them for 2-4 hours, filtering, and drying the filtrate at 60-80° C. to obtain a Chinese medicine ointment for later use;
(2)精确称量0.55-0.75g聚丙烯酸钠、0.45-0.65g高岭土和6.5-7.5g甘油,混匀作为A相,备用;(2) Accurately weigh 0.55-0.75 g of sodium polyacrylate, 0.45-0.65 g of kaolin, and 6.5-7.5 g of glycerol, mix well as phase A, and set aside;
(3)精确称量0.03-0.05g甘氨酸铝、10-14g酒石酸和0.2-0.4g薄荷脑,混匀作为B相,备用;(3) Accurately weigh 0.03-0.05 g aluminum glycinate, 10-14 g tartaric acid, and 0.2-0.4 g menthol, mix well as phase B, and set aside;
(4)将A相置于60-80℃的水浴锅上加热,快速搅拌6-8min,后把B相加入A相中,继续快速搅拌6-8min,得到凝胶基质,备用;(4) Heat phase A in a water bath at 60-80° C. and stir rapidly for 6-8 minutes. Then add phase B to phase A and continue stirring rapidly for 6-8 minutes to obtain a gel matrix for later use.
(5)将中药药膏加入凝胶基质中,搅拌20-30min,将得到的膏体平铺在8cm*12cm的无纺布上,放于阴凉处待它冷却凝固,即得凝胶贴膏剂。(5) Add the Chinese medicine ointment to the gel matrix and stir for 20-30 minutes. Spread the obtained paste on a non-woven fabric of 8 cm*12 cm and place it in a cool place until it cools and solidifies to obtain a gel patch.
前述步骤(1)中,按照处方比例称取药材,进行粉碎成粗,用电子分析天平精确称量药材总质量为17.1g,用15倍的乙醇进行浸泡24h,再回流提取3h,过滤,取滤液在70℃条件下进行干燥,得到中药药膏,备用。In the above step (1), the medicinal materials are weighed according to the prescription ratio, crushed into coarse pieces, and the total mass of the medicinal materials is accurately weighed with an electronic analytical balance to be 17.1 g. The medicinal materials are soaked in 15 times ethanol for 24 hours, refluxed for extraction for 3 hours, filtered, and the filtrate is dried at 70° C. to obtain a Chinese medicine ointment for later use.
前述步骤(2)中,精确称量0.63g聚丙烯酸钠、0.55g高岭土和7g甘油,作为A相,备用。In the above step (2), 0.63 g of sodium polyacrylate, 0.55 g of kaolin and 7 g of glycerol were accurately weighed as phase A for later use.
前述步骤(3)中,精确称量0.04g甘氨酸铝、12g酒石酸和0.3g薄荷脑,作为B相,备用。In the above step (3), accurately weigh 0.04 g of aluminum glycinate, 12 g of tartaric acid and 0.3 g of menthol as phase B for later use.
前述步骤(4)中,将A相置于70℃的水浴锅上加热,快速搅拌7min,后把B相加入A相中,继续快速搅拌7min,得到凝胶基质,备用;In the above step (4), phase A is placed in a water bath at 70° C. and heated, and rapidly stirred for 7 minutes. Phase B is then added to phase A, and rapidly stirred for 7 minutes to obtain a gel matrix for later use;
前述步骤(5)中,将中药药膏加入凝胶基质中,搅拌25min,将得到的膏体平铺在8cm*12cm的无纺布上,放于阴凉处待它冷却凝固,即得凝胶贴膏剂。In the above step (5), the Chinese medicine ointment is added to the gel matrix and stirred for 25 minutes. The obtained paste is spread on a non-woven fabric of 8 cm*12 cm and placed in a cool place to cool and solidify, thereby obtaining a gel patch.
与现有技术相比,本发明具有以下有益效果:Compared with the prior art, the present invention has the following beneficial effects:
本发明所述治疗痹痛的凝胶贴膏剂由制川乌、北细辛、苍术、独活、牛膝、全当归、穿山龙、千年健、追地风、威灵仙、松节、红禾麻、桑寄生、狗脊、五加皮、鸡血藤、三棱、莪术制成。其中川乌为毛茛科植物乌头Aconitumcarmichaelii Debx.的干燥母根;6月下旬至8月上旬采挖,除去子根、须根及泥沙,晒干;味辛、苦,性热;有大毒;归心、肝、肾、脾经;具有祛风除湿,温经止痛的功效;用于风寒湿痹,关节疼痛,心腹冷痛,寒疝作痛及麻醉止痛;制川乌为川乌的炮制加工品。北细辛为马觉铃科植物北细辛AsarumheterotropoidesFr.Schmidt var.man dshuricum(Maxim.)Kitag.的干燥根和根莲;夏季果熟期或初秋采挖,除净地上部分和泥沙,阴干;味辛,性温;归心、肺、肾经;具有解表散寒,祛风止痛,通窍,温肺化饮的功效;用于风寒感冒,头痛,牙痛,鼻塞流涕,鼻鼽,鼻渊,风湿痹痛,痰饮喘咳。苍术为菊科植物茅苍术Atractylodes lancea(Thunb.)DC.或北苍术Atractylodeschinensis(DC.)Koidz.的干燥根茎;舂、秋二季采挖,除去泥沙,晒干,撞去须根;味辛、苦,性温;归脾、胃、肝经;具有燥湿徤脾,祛风散寒,明目的功效;用于湿阻中焦,脘腹胀满,泄泻,水肿,脚气痿蹵,风湿痹痛,风寒感冒,夜盲,眼目昏涩。独活为伞形科植物重齿毛当归Angelica pubescens Maxim.f.biserrataShan et Yuan的干燥根;春初苗刚发芽或秋末茎叶枯萎时釆挖,除去须根和泥沙,烘至半干,堆置2~3天,发软后再烘至全干;味辛、苦,性微温;归肾、膀胱经;具有祛风除湿,通痹止痛的功效;用于风寒湿痹,腰膝疼痛,少阴伏风头痛,风寒挟湿头痛。牛膝为苋科植物牛膝Achyranthes bidentata Bl.的干燥根;味苦、甘、酸,性平;归肝、肾经;具有逐瘀通经,补肝肾,强筋骨,利尿通淋,引血下行的功效;用于经闭,痛经,腰膝酸痛,筋骨无力,淋证,水肿,头痛,眩晕,牙痛,口疮,吐血,衄血。当归为伞形科植物当归Angelica sinensis(Oliv.)Diels的干燥根;秋末采挖,除去须根和泥沙,待水分稍蒸发后,捆成小把,上棚,用烟火慢慢熏干;全当归包括当归的头、中、尾;味甘、辛,性温;归肝、心、脾经;具有补血活血,调经止痛,润肠通便的功效;用于血虚萎黄,眩晕心悸,月经不调,闭经痛经,虚寒腹痛,风湿痹痛,跌扑损伤,痈疽疮疡,肠燥便秘;酒当归活血通经;用于闭经痛经,风湿痹痛,跌扑损伤。穿山龙为薯蓣科植物穿龙薯蓣Dioscorea nipponicaMakino的干燥根茎;春、秋二季采挖,洗净,除去须根和外皮,晒干;味甘、苦,性温;归肝、肾、肺经;具有祛风除湿,舒筋通络,活血止痛,化痰止咳的功效;用于风湿痹病,关节肿胀,疼痛麻木,跌扑损伤,闪腰岔气,咳嗽气喘。千年健为天南星科植物千年健Homalomena occulta(Lour.)Schott的干燥根茎;味苦、辛,性温。归肝、肾经;具有祛风湿,壮筋骨的功效;用于风寒湿痹,腰膝冷痛,拘挛麻木,筋骨痿软。追地风又名地枫皮为木兰科植物地枫皮Illiciumdifengpi K.I.B.et K.I.M.的干燥树皮;味微辛、涩,性温;有小毒;归膀胱、肾经;具有祛风除湿,行气止痛的功效;用于风湿痹痛,劳伤腰痛。威灵仙为毛茛科植物威灵仙Clematischinensis Osbeck、棉团铁线莲Clematis hexapetala Pall.或东北铁线莲Clematis manshurica Rupr.的干燥根和根茎;味辛、咸,性温;归膀胱经;具有祛风湿,通经络的功效;用于风湿痹痛,肢体麻木,筋脉拘挛,屈伸不利。松节为松科植物云南松(Pinusyunnanensis Franch)的枝干结节;味苦,性温;具有祛风燥湿,舒筋活络,活血止血的功效;用于治疗关节疼痛,筋骨栾急,脚痹痿软,跌仆疼痛。红禾麻为荨麻科植物珠芽艾麻(Laportea bulbifera(Sieb.etZace)Wedd.)的根,味辛,性温;具有祛风除湿,活血化瘀的功效;主治风湿痹痛,肢体麻木,跌仆损伤,骨折疼痛,月经不调。桑寄生为桑寄生科植物桑寄生Taxillus chinensis(DC.)Danser的干燥带叶茎枝;冬季至次春采割,除去粗茎,切段,干燥,或蒸后干燥;味苦、甘,性平;归肝、肾经;具有祛风湿,补肝肾,强筋骨,安胎元的功效;用于风湿痹痛,腰膝酸软,筋骨无力,崩漏经多,妊娠漏血,胎动不安,头晕目眩。狗脊为蚌壳蕨科植物金毛狗脊Cibotiumbarometz(L.)J.Sm.的干燥根茎;味苦、甘,性温;归肝、肾经;具有祛风湿,补肝肾,强腰膝的功效;用于风湿痹痛,腰膝酸软,下肢无力。五加皮为五加科植物细柱五加Acanthopanax gracilistylus W.W.Smith的干燥根皮;味辛、苦,性温;归肝、肾经;具有祛风除湿,补益肝肾,强筋壮骨,利水消肿的功效;用于风湿痹病,筋骨痿软,小儿行迟,体虚乏力,水肿,脚气。鸡血藤为豆科植物密花豆Spatholobus suberectus Dunn的干燥藤茎;味苦、甘,性温;归肝、肾经;具有活血补血,调经止痛,舒筋活络的功效;用于月经不调,痛经,经闭,风湿痹痛,麻木瘫痪,血虚萎黄。三棱为黑三棱科植物黑三棱Sparganiumstoloniferum Buch.-Ham.的干燥块茎;味辛、苦,性平;归肝、脾经;具有破血行气,消积止痛的功效;用于癥瘕痞块,痛经,瘀血经闭,胸痹心痛,食积胀痛。莪术为姜科植物蓬莪术Curcuma phaeocaulis VaL.、广西莪术CurcumakuuangsiensisS.G.LeeetC.F.Liang或温郁金Curcuma wenyujinY.H.ChenetC.Ling的干燥根茎;味辛、苦,性温;归肝、脾经;具有行气破血,消积止痛的功效;用于癥瘕痞块,瘀血经闭,胸痹心痛,食积胀痛。The gel plaster for treating arthralgia of the present invention is prepared from processed Chuanwu, Asarum, Atractylodes, Angelicae Pubescentis, Achyranthes bidentata, Angelica sinensis, Rhizoma Dioscoreae, Rhizoma Cibotii, Rhizoma Cibotii, Rhizoma Cibotii, Rhizoma Acanthopanacis, Caulis Spatholobi, Rhizoma Tripterygii, and Rhizoma Curcumae. Chuanwu is the dried mother root of Aconitumcarmichaelii Debx. of the Ranunculaceae family; it is excavated from late June to early August, the sub-roots, fibrous roots and mud and sand are removed, and it is dried in the sun; it is pungent and bitter in taste, hot in nature, highly toxic, and enters the heart, liver, kidney and spleen meridians; it has the effects of dispelling wind and dampness, warming the meridians and relieving pain; it is used for wind-cold-damp arthralgia, joint pain, cold pain in the heart and abdomen, pain caused by cold hernia and anesthesia and analgesia; processed Chuanwu is a processed product of Chuanwu. Asarum is the dried root and rhizome of Asarumheterotropoides Fr. Schmidt var. mandshuricum (Maxim.) Kitag., a plant of the Aquilegiaceae family. It is dug up in summer when the fruit is ripe or in early autumn, and the above-ground parts and mud and sand are removed, and then dried in the shade. It tastes spicy and is warm in nature. It enters the heart, lung, and kidney meridians. It has the effects of dispelling cold, dispelling wind and relieving pain, opening the orifices, warming the lungs and transforming fluid. It is used for colds caused by wind and cold, headaches, toothaches, nasal congestion and runny nose, allergic rhinitis, sinusitis, rheumatic pain, and coughs with phlegm and fluid. Atractylodes lancea is the dried rhizome of Atractylodes lancea (Thunb.) DC. or Atractylodes chinensis (DC.) Koidz. of the Asteraceae family. It is dug up in spring and autumn, the sand is removed, it is dried in the sun, and the fibrous roots are removed. It tastes pungent and bitter and is warm in nature. It enters the spleen, stomach, and liver meridians. It has the effects of drying dampness and spleen, dispelling wind and cold, and improving eyesight. It is used for dampness blocking the middle jiao, abdominal distension, diarrhea, edema, beriberi, rheumatism, colds, night blindness, and blurred vision. Duhuo is the dried root of Angelica pubescens Maxim.f.biserrata Shan et Yuan, a plant of the Apiaceae family. It is dug when the seedlings just sprout in early spring or when the stems and leaves wither in late autumn, and the fibrous roots and mud are removed, and it is dried to half dry, piled for 2 to 3 days, and then dried to completely dry after it softens. It tastes pungent and bitter, and is slightly warm in nature. It enters the kidney and bladder meridians. It has the effects of dispelling wind and dampness, relieving numbness and relieving pain. It is used for wind-cold-dampness arthritis, pain in the waist and knees, headache caused by the hidden wind of Shaoyin, and headache caused by wind-cold and dampness. Achyranthes bidentata is the dried root of Achyranthes bidentata Bl., a plant of the Amaranthaceae family. It tastes bitter, sweet, and sour, and is neutral in nature. It enters the liver and kidney meridians. It has the effects of removing blood stasis and relieving menstruation, nourishing the liver and kidney, strengthening the tendons and bones, promoting diuresis and relieving stranguria, and guiding blood downward. It is used for amenorrhea, dysmenorrhea, soreness of the waist and knees, weakness of the tendons and bones, stranguria, edema, headache, dizziness, toothache, mouth sores, vomiting blood, and epistaxis. Angelica sinensis is the dried root of Angelica sinensis (Oliv.) Diels of the Umbelliferae family. It is dug up in late autumn, and the fibrous roots and mud are removed. After the water evaporates slightly, it is tied into small bundles, hung on a shed, and slowly smoked dry with fireworks. The whole angelica includes the head, middle, and tail of the angelica. It tastes sweet and spicy and is warm in nature. It enters the liver, heart, and spleen meridians. It has the effects of nourishing blood and activating blood circulation, regulating menstruation and relieving pain, and moistening the intestines and relieving constipation. It is used for blood deficiency and sallow complexion, dizziness and palpitations, irregular menstruation, amenorrhea and dysmenorrhea, abdominal pain due to deficiency and cold, rheumatism, injuries due to falls, carbuncles, and ulcers, and dry intestines and constipation. Wine-boiled angelica can activate blood circulation and regulate menstruation; it is used for amenorrhea and dysmenorrhea, rheumatism, and injuries due to falls. Dioscorea nipponica Makino is a dried rhizome of Dioscorea nipponica Makino, a plant of the Dioscoreaceae family. It is dug in spring and autumn, washed, the fibrous roots and skin are removed, and dried in the sun. It tastes sweet and bitter, and is warm in nature. It enters the liver, kidney, and lung meridians. It has the effects of dispelling wind and dampness, relaxing muscles and tendons, activating blood circulation and relieving pain, and resolving phlegm and relieving cough. It is used for rheumatism, joint swelling, pain and numbness, injuries from falls, sprains, and coughs and asthma. Homalomena occulta (Lour.) Schott is a dried rhizome of Homalomena occulta (Lour.) Schott, a plant of the Araceae family. It tastes bitter and pungent, and is warm in nature. It enters the liver and kidney meridians. It has the effects of dispelling rheumatism and strengthening tendons and bones. It is used for wind-cold and dampness, cold pain in the waist and knees, cramps and numbness, and weakness of tendons and bones. Difeng, also known as Difengpi, is the dried bark of Illiciumdifengpi K.I.B.et K.I.M., a plant of the Magnoliaceae family. It tastes slightly pungent and astringent, and is warm in nature. It is slightly toxic. It enters the bladder and kidney meridians. It has the effects of dispelling wind and dampness, promoting qi and relieving pain. It is used for rheumatic pain and back pain caused by overwork. Clematis chinensis is the dried root and rhizome of Clematischinensis Osbeck, Clematis hexapetala Pall. or Clematis manshurica Rupr., a plant of the Ranunculaceae family. It tastes pungent and salty, and is warm in nature. It enters the bladder meridian. It has the effects of dispelling wind and rheumatism and unblocking meridians. It is used for rheumatic pain, numbness of limbs, cramps of tendons and veins, and difficulty in flexion and extension. Pine knots are the branches and trunks of the Yunnan pine (Pinusyunnanensis Franch) of the Pinaceae family. They are bitter and warm in nature. They have the effects of dispelling wind and dampness, relaxing muscles and tendons, activating blood circulation and stopping bleeding. They are used to treat joint pain, stiffness of tendons and bones, numbness and weakness of feet, and pain caused by falls. Red hemp is the root of Laportea bulbifera (Sieb.etZace) Wedd. of the Urticaceae family. They are pungent and warm in nature. They have the effects of dispelling wind and dampness, activating blood circulation and removing blood stasis. They are mainly used to treat rheumatic pain, numbness of limbs, injuries caused by falls, pain caused by fractures, and irregular menstruation. Mulberry is the dried stems and branches with leaves of Taxillus chinensis (DC.) Danser, a plant of the family Loranaceae; harvested from winter to the next spring, the thick stems removed, cut into sections, dried, or steamed and dried; bitter and sweet in taste, neutral in nature; enters the liver and kidney meridians; has the effects of removing rheumatism, nourishing the liver and kidney, strengthening the tendons and bones, and calming the fetus; used for rheumatic pain, soreness of the waist and knees, weakness of the tendons and bones, metrorrhagia, bleeding during pregnancy, restless fetal movement, and dizziness. Cibotium barometz is the dried rhizome of Cibotium barometz (L.) J. Sm., a plant of the family Pteridaceae; bitter and sweet in taste, warm in nature; enters the liver and kidney meridians; has the effects of removing rheumatism, nourishing the liver and kidney, and strengthening the waist and knees; used for rheumatic pain, soreness of the waist and knees, and weakness of the lower limbs. Acanthopanax bark is the dried root bark of Acanthopanax gracilistylus W.W.Smith, a plant of the Araliaceae family; it is pungent and bitter in taste, warm in nature; it enters the liver and kidney meridians; it has the effects of dispelling wind and dampness, nourishing the liver and kidney, strengthening tendons and bones, promoting diuresis and reducing swelling; it is used for rheumatic arthralgia, weak tendons and bones, delayed walking in children, physical weakness, edema, and beriberi. Millettia reticulata is the dried vine stem of Spatholobus suberectus Dunn, a plant of the Leguminosae family; it is bitter and sweet in taste, warm in nature; it enters the liver and kidney meridians; it has the effects of promoting blood circulation and replenishing blood, regulating menstruation and relieving pain, and relaxing tendons and activating collaterals; it is used for irregular menstruation, dysmenorrhea, amenorrhea, rheumatic arthralgia, numbness and paralysis, and anemia and chlorosis. Sparganium is the dried tuber of Sparganiumstoloniferum Buch.-Ham. of the family Sparganium; it is pungent and bitter, and neutral in nature; it enters the liver and spleen meridians; it has the effects of breaking blood and promoting qi, eliminating accumulation and relieving pain; it is used for lumps and masses, dysmenorrhea, amenorrhea due to blood stasis, chest pain, and distension and pain caused by food accumulation. Curcuma is the dried rhizome of Curcuma phaeocaulis VaL., Curcuma kuangsiensis S.G.LeeetC.F.Liang or Curcuma wenyujin Y.H.ChenetC.Ling of the family Zingiberaceae; it is pungent and bitter, and warm in nature; it enters the liver and spleen meridians; it has the effects of promoting qi and breaking blood, eliminating accumulation and relieving pain; it is used for lumps and masses, amenorrhea due to blood stasis, chest pain, and distension and pain caused by food accumulation.
方解:Solution:
痹证主要病机为风寒湿邪阻滞经络导致气血运行不畅,方中追地风、穿山龙、千年健能祛风除湿、强筋健骨、活血止痛为君药;威灵仙、鸡血藤、红禾麻能祛风除湿、疏通经络;痹证日久耗伤气血而累及肝肾,故用桑寄生、狗脊、五加皮等能祛风湿补肝肾强筋骨;川乌能祛风除湿、散寒止痛,以上为臣药助君药祛风除湿、强筋健骨、活血止痛;北细辛能搜筋骨风寒湿邪,通络止痛;松节、苍术健脾燥湿;独活能祛风散寒、胜湿止痛;风湿痹痛久病入络,瘀血痰浊阻痹经络,非破血之品不能化之,故用全当归、三棱、莪术等既破血化瘀、行气止痛,又寓“治风先治血,血行风自灭”之意,以上为佐药;牛膝补肝肾强筋骨且引药下行以通利经络,为佐使药。诸药合用,共奏祛风除湿、强筋健骨、化瘀止痛之功。The main pathogenesis of arthralgia is that wind, cold and dampness block the meridians, resulting in poor circulation of qi and blood. In the prescription, Zhui Di Feng, Chuan Shan Long and Qian Nian Jian can dispel wind and dampness, strengthen tendons and bones, and promote blood circulation and relieve pain. They are the main drugs; Wei Ling Xian, Millettia reticulata and Hong He Ma can dispel wind and dampness and dredge the meridians; arthralgia consumes qi and blood over a long period of time and affects the liver and kidneys, so mistletoe, dog spine, and Acanthopanax can dispel rheumatism, nourish the liver and kidneys, and strengthen tendons and bones; Chuan Wu can dispel wind and dampness, dispel cold and relieve pain. The above are assistant drugs that help the main drugs dispel wind and dampness, strengthen tendons and bones, and promote blood circulation and relieve pain. Bone, blood circulation and pain relief; Asarum can search for wind, cold and dampness in tendons and bones, unblock meridians and relieve pain; Pine knot and Atractylodes can invigorate the spleen and dry dampness; Duhuo can dispel wind and cold, overcome dampness and relieve pain; Rheumatism and arthralgia can enter the meridians for a long time, and blood stasis and phlegm can block the meridians, which cannot be resolved without blood-breaking products. Therefore, whole Angelica, Trigonosciadium japonicum, Curcuma zedoaria, etc. are used to break blood and dissolve blood stasis, promote qi and relieve pain, and also imply the meaning of "treating wind first treat blood, and blood circulation will eliminate wind by itself". The above are adjuvant drugs; Achyranthes bidentata can nourish the liver and kidney, strengthen tendons and bones, and guide the drugs downward to unblock meridians, which is an adjuvant drug. All the drugs are used together to play the role of dispelling wind and dampness, strengthening tendons and bones, removing blood stasis and relieving pain.
与现有技术相比,有益效果如下:Compared with the prior art, the beneficial effects are as follows:
1、正交试验法做提取工艺和寻找基质配方便捷、可靠,最优基质处方下贴膏有较好的黏性和成型性,高效液相法检测齐墩果酸含量最高能达到为0.05%含量,质量标准稳定,复方痹痛贴膏剂制备工艺可行,达到课题设计的预期目的。1. The orthogonal test method is convenient and reliable for extraction process and finding matrix formula. The plaster has good viscosity and formability under the optimal matrix formula. The oleanolic acid content detected by HPLC can reach a maximum of 0.05%. The quality standard is stable. The preparation process of Compound Bitong Plaster is feasible, achieving the expected purpose of the project design.
痹痛方低、高剂量组与醋酸泼尼松组对二甲苯致小鼠耳肿胀均有明显的抑制作用,可降低小鼠的耳肿胀,提示痹痛方具有良好的抗炎作用。各给药小组通过与空白对照组比较,具有统计学意义(p<0.05)。其中,痹痛方高剂量组肿胀度明显小于低剂量组,说明高剂量组抗炎效果比低剂量组好。因此,本发明具有良好的镇痛、抑制炎症作用,能明显减少小鼠由醋酸对腹腔刺激而产生的扭体次数和抑制二甲苯导致的小鼠耳肿胀。The low-dose and high-dose groups of Bitong Fang and the prednisone acetate group all have a significant inhibitory effect on the ear swelling of mice caused by xylene, and can reduce the ear swelling of mice, indicating that Bitong Fang has a good anti-inflammatory effect. Each drug-administered group was compared with the blank control group, and there was statistical significance (p < 0.05). Among them, the swelling degree of the high-dose group of Bitong Fang was significantly less than that of the low-dose group, indicating that the high-dose group had a better anti-inflammatory effect than the low-dose group. Therefore, the present invention has a good analgesic and anti-inflammatory effect, can significantly reduce the number of twistings caused by acetic acid to the abdominal cavity of mice and inhibit the ear swelling of mice caused by xylene.
实验优选出的处方配制而成的凝胶贴膏具有良好的涂布性,质地平整且均一,膏面柔软光洁,没有明显大颗粒,气泡少,粘黏性好且无残留。这款痹痛凝胶贴膏剂是坚守中医药的特色优势,运用现代制备设备及现代中药巴布剂经皮给药技术,对传统中药贴敷制剂进行创新改造而成,这是对传统中药贴敷剂的创新发展,对中医药创新发展具有现实及深远的意义。The gel patch prepared by the optimal formula in the experiment has good coating properties, smooth and uniform texture, soft and smooth surface, no obvious large particles, few bubbles, good viscosity and no residue. This Bitong gel patch adheres to the unique advantages of traditional Chinese medicine, uses modern preparation equipment and modern Chinese medicine cataplasm transdermal drug delivery technology, and innovates and transforms traditional Chinese medicine patch preparations. This is an innovative development of traditional Chinese medicine patches, and has practical and far-reaching significance for the innovative development of traditional Chinese medicine.
附图说明BRIEF DESCRIPTION OF THE DRAWINGS
图1:实施例1药材浸泡过程图;Figure 1: Diagram of the medicinal material soaking process in Example 1;
图2:实施例1中药药膏;Figure 2: Chinese medicine ointment of Example 1;
图3:实施例1凝胶贴膏剂Figure 3: Gel patch of Example 1
图4:齐墩果酸含量检测对照品谱图;Figure 4: Spectrum of oleanolic acid content detection reference substance;
图5:齐墩果酸含量检测供试品1号谱图;Figure 5: Spectrum of test sample No. 1 for oleanolic acid content detection;
图6:齐墩果酸含量检测供试品2号谱图;Figure 6: Spectrum of test sample No. 2 for oleanolic acid content detection;
图7:高效液相色谱法测齐墩果酸含量标准曲线;Figure 7: Standard curve of oleanolic acid content measured by HPLC;
图8:小鼠扭体实验过程图;Figure 8: Diagram of the process of mouse writhing experiment;
图9:二甲苯致耳肿胀实验过程图。Figure 9: Diagram of the xylene-induced ear swelling experiment process.
具体实施方式DETAILED DESCRIPTION
下面结合实施例对本发明作进一步的说明,但并不作为对本发明限制的依据。The present invention will be further described below in conjunction with the embodiments, but they are not intended to limit the present invention.
实施例1。Example 1.
处方:制川乌12g、北细辛6g、苍术9g、独活9g、牛膝9g、全当归12g、穿山龙30g、千年健30g、追地风30g、威灵仙18g、松节15g、红禾麻10g、桑寄生12g、狗脊12g、五加皮12g、鸡血藤15g、三棱12g、莪术12g。Prescription: processed Chuanwu 12g, northern Asarum 6g, Atractylodes 9g, Duhuo 9g, Achyranthes bidentata 9g, whole Angelica 12g, Rhizoma Cynoglossi 30g, Rhizoma Cibotii 30g, Radix Achyranthis Bidentatae 30g, Clematidis 18g, Turpentine 15g, Hemp 10g, Viscum album 12g, Cibotium bark 12g, Acanthopanax cortex 12g, Millettia reticulata 15g, Trillium 12g, Curcuma 12g.
工艺:(1)按照处方比例称取药材,进行粉碎成粗,用电子分析天平精确称量药材总质量为17.1g,用15倍的乙醇进行浸泡24h,再回流提取3h,过滤,取滤液在70℃条件下进行干燥,得到中药药膏,备用;Process: (1) Weigh the medicinal materials according to the prescription ratio, crush them into coarse pieces, accurately weigh the total mass of the medicinal materials to be 17.1 g using an electronic analytical balance, soak them in 15 times ethanol for 24 hours, reflux extract for 3 hours, filter, and dry the filtrate at 70° C. to obtain a Chinese medicine ointment for later use;
(2)精确称量0.63g聚丙烯酸钠、0.55g高岭土和7g甘油,作为A相,备用;(2) Accurately weigh 0.63 g of sodium polyacrylate, 0.55 g of kaolin, and 7 g of glycerol as phase A and set aside;
(3)精确称量0.04g甘氨酸铝、12g酒石酸和0.3g薄荷脑,作为B相,备用;(3) Accurately weigh 0.04 g aluminum glycinate, 12 g tartaric acid, and 0.3 g menthol as phase B and set aside;
(4)将A相置于70℃的水浴锅上加热,快速搅拌7min,后把B相加入A相中,继续快速搅拌7min,得到凝胶基质,备用;(4) Heat phase A in a water bath at 70°C and stir rapidly for 7 minutes, then add phase B to phase A and continue stirring rapidly for 7 minutes to obtain a gel matrix for later use;
(5)将中药药膏加入凝胶基质中,搅拌25min,将得到的膏体平铺在8cm*12cm的无纺布上,放于阴凉处待它冷却凝固,即得凝胶贴膏剂。(5) Add the Chinese medicine ointment to the gel matrix and stir for 25 minutes. Spread the obtained paste on a non-woven fabric of 8 cm*12 cm and place it in a cool place until it cools and solidifies to obtain a gel patch.
用法用量:每12小时用一张凝胶贴膏剂,10天为一个疗程。Dosage and Administration: Use one gel patch every 12 hours, 10 days as a course of treatment.
实施例2。Example 2.
处方:制川乌9g、北细辛4g、苍术6g、独活6g、牛膝6g、全当归9g、穿山龙20g、千年健20g、追地风20g、威灵仙13g、松节10g、红禾麻10、桑寄生9、狗脊9、五加皮9、鸡血藤10、三棱9、莪术9。Prescription: processed Chuanwu 9g, northern Asarum 4g, Atractylodes 6g, Duhuo 6g, Achyranthes bidentata 6g, whole Angelica 9g, Rhizoma Cynoglossi 20g, Rhizoma Cibotii 20g, Radix Clematis 13g, pine knot 10g, red hemp 10, mistletoe 9, Cibotium bark 9, Acanthopanax cortex 9, Millettia reticulata 10, Trillium 9, Curcuma 9.
工艺:(1)按照处方比例称取药材,进行粉碎成粗,用电子分析天平精确称量药材总质量为15g,用12倍的乙醇进行浸泡18h,再回流提取2h,过滤,取滤液在60℃条件下进行干燥,得到中药药膏,备用;Process: (1) Weigh the medicinal materials according to the prescription ratio, crush them into coarse powder, accurately weigh the total mass of the medicinal materials to 15 g using an electronic analytical balance, soak them in 12 times ethanol for 18 hours, reflux extract for 2 hours, filter, and dry the filtrate at 60° C. to obtain a Chinese medicine ointment for later use;
(2)精确称量0.55g聚丙烯酸钠、0.45g高岭土和6.5g甘油,混匀作为A相,备用;(2) Accurately weigh 0.55 g of sodium polyacrylate, 0.45 g of kaolin, and 6.5 g of glycerol, mix well as phase A, and set aside;
(3)精确称量0.03g甘氨酸铝、10g酒石酸和0.2g薄荷脑,混匀作为B相,备用;(3) Accurately weigh 0.03 g aluminum glycinate, 10 g tartaric acid, and 0.2 g menthol, mix well as phase B, and set aside;
(4)将A相置于60℃的水浴锅上加热,快速搅拌6min,后把B相加入A相中,继续快速搅拌6min,得到凝胶基质,备用;(4) Heat phase A in a water bath at 60°C and stir rapidly for 6 min. Then add phase B to phase A and continue stirring rapidly for 6 min to obtain a gel matrix for later use.
(5)再将中药药膏加入凝胶基质中,搅拌20min,将得到的膏体平铺在8cm*12cm的无纺布上,放于阴凉处待它冷却凝固,即得凝胶贴膏剂。(5) Add the Chinese medicine ointment to the gel matrix and stir for 20 minutes. Spread the resulting paste on a non-woven fabric of 8 cm*12 cm and place it in a cool place until it cools and solidifies to obtain a gel patch.
用法用量:每12小时用一张凝胶贴膏剂,10天为一个疗程。Dosage and Administration: Use one gel patch every 12 hours, 10 days as a course of treatment.
实施例3。Example 3.
处方:制川乌15g、北细辛8g、苍术12g、独活12g、牛膝12g、全当归15g、穿山龙40g、千年健40g、追地风40g、威灵仙23g、松节20g、红禾麻20g、桑寄生15g、狗脊15g、五加皮15g、鸡血藤20g、三棱15g、莪术15g。Prescription: processed Chuanwu 15g, northern Asarum 8g, Atractylodes 12g, Duhuo 12g, Achyranthes bidentata 12g, whole Angelica 15g, Rhizoma Cynoglossi 40g, Rhizoma Cibotii 40g, Radix Achyranthis Bidentatae 40g, Clematidis 23g, Turpentine 20g, Hemp 20g, Viscum album 15g, Cibotium bark 15g, Acanthopanax cortex 15g, Millettia reticulata 20g, Trillium 15g, Curcuma 15g.
工艺:(1)按照处方比例称取药材,进行粉碎成粗,用电子分析天平精确称量药材总质量为20g,用18倍的乙醇进行浸泡30h,再回流提取4h,过滤,取滤液在80℃条件下进行干燥,得到中药药膏,备用;Process: (1) Weigh the medicinal materials according to the prescription ratio, crush them into coarse powder, accurately weigh the total mass of the medicinal materials to 20 g using an electronic analytical balance, soak them in 18 times ethanol for 30 hours, reflux extract for 4 hours, filter, and dry the filtrate at 80° C. to obtain a Chinese medicine ointment for later use;
(2)精确称量0.75g聚丙烯酸钠、0.65g高岭土和7.5g甘油,混匀作为A相,备用;(2) Accurately weigh 0.75 g of sodium polyacrylate, 0.65 g of kaolin, and 7.5 g of glycerol, mix well as phase A, and set aside;
(3)精确称量0.05g甘氨酸铝、14g酒石酸和0.4g薄荷脑,混匀作为B相,备用;(3) Accurately weigh 0.05 g aluminum glycinate, 14 g tartaric acid, and 0.4 g menthol, mix well as phase B, and set aside;
(4)将A相置于80℃的水浴锅上加热,快速搅拌8min,后把B相加入A相中,继续快速搅拌8min,得到凝胶基质,备用;(4) Heat phase A in a water bath at 80°C and stir rapidly for 8 minutes, then add phase B into phase A and continue stirring rapidly for 8 minutes to obtain a gel matrix for later use;
(5)再将中药药膏加入凝胶基质中,搅拌30min,将得到的膏体平铺在8cm*12cm的无纺布上,放于阴凉处待它冷却凝固,即得凝胶贴膏剂。(5) Add the Chinese medicine ointment to the gel matrix and stir for 30 minutes. Spread the resulting paste on a non-woven fabric of 8 cm*12 cm and place it in a cool place until it cools and solidifies to obtain a gel patch.
用法用量:每12小时用一张凝胶贴膏剂,10天为一个疗程。Dosage and Administration: Use one gel patch every 12 hours, 10 days as a course of treatment.
实施例4。Example 4.
处方:制川乌11g、北细辛8g、苍术8g、独活10g、牛膝12g、全当归9g、穿山龙25g、千年健30g、追地风40g、威灵仙22g、松节10g、红禾麻12g、桑寄生15g、狗脊14g、五加皮12g、鸡血藤20g、三棱10g、莪术15g。Prescription: processed Chuanwu 11g, northern asarum 8g, Atractylodes 8g, Duhuo 10g, Achyranthes bidentata 12g, whole Angelica 9g, Rhizoma Cynoglossi 25g, Rhizoma Cibotii 30g, Rhizoma Dioscoreae 40g, Clematidis 22g, Turpentine 10g, Hemp 12g, Viscum album 15g, Cibotium bark 14g, Acanthopanax acanthopanax 12g, Millettia reticulata 20g, Trillium 10g, Curcuma 15g.
工艺:(1)按照处方比例称取药材,进行粉碎成粗,用电子分析天平精确称量药材总质量为18g,用14倍的乙醇进行浸泡28h,再回流提取2h,过滤,取滤液在65℃条件下进行干燥,得到中药药膏,备用;Process: (1) Weigh the medicinal materials according to the prescription ratio, crush them into coarse powder, accurately weigh the total mass of the medicinal materials to be 18 g using an electronic analytical balance, soak them in 14 times ethanol for 28 hours, reflux extract for 2 hours, filter, and dry the filtrate at 65° C. to obtain a Chinese medicine ointment for later use;
(2)精确称量0.65g聚丙烯酸钠、0.50g高岭土和7.5g甘油,混匀作为A相,备用;(2) Accurately weigh 0.65 g of sodium polyacrylate, 0.50 g of kaolin, and 7.5 g of glycerol, mix well as phase A, and set aside;
(3)精确称量0.035g甘氨酸铝、11g酒石酸和0.35g薄荷脑,混匀作为B相,备用;(3) Accurately weigh 0.035 g aluminum glycinate, 11 g tartaric acid, and 0.35 g menthol, mix well as phase B, and set aside;
(4)将A相置于65℃的水浴锅上加热,快速搅拌8min,后把B相加入A相中,继续快速搅拌8min,得到凝胶基质,备用;(4) Heat phase A in a water bath at 65°C and stir rapidly for 8 minutes, then add phase B into phase A and continue stirring rapidly for 8 minutes to obtain a gel matrix for later use;
(5)再将中药药膏加入凝胶基质中,搅拌25min,将得到的膏体平铺在8cm*12cm的无纺布上,放于阴凉处待它冷却凝固,即得凝胶贴膏剂。(5) Add the Chinese medicine ointment to the gel matrix and stir for 25 minutes. Spread the resulting paste on a non-woven fabric of 8 cm*12 cm and place it in a cool place until it cools and solidifies to obtain a gel patch.
用法用量:每12小时用一张凝胶贴膏剂,10天为一个疗程。Dosage and Administration: Use one gel patch every 12 hours, 10 days as a course of treatment.
实施例5。Example 5.
处方:制川乌9g、北细辛4g、苍术10g、独活12g、牛膝7g、全当归12g、穿山龙40g、千年健30g、追地风35g、威灵仙15g、松节10g、红禾麻10g、桑寄生15g、狗脊11g、五加皮9g、鸡血藤18g、三棱13g、莪术13g。Prescription: processed Chuanwu 9g, northern Asarum 4g, Atractylodes 10g, Duhuo 12g, Achyranthes bidentata 7g, whole Angelica 12g, Rhizoma Cynoglossi 40g, Rhizoma Cibotii 30g, Rhizoma Dioscoreae 35g, Clematidis 15g, Turpentine 10g, Hemp 10g, Viscum album 15g, Cibotium bark 11g, Acanthopanax cortex 9g, Millettia reticulata 18g, Trillium 13g, Curcuma 13g.
工艺:(1)按照处方比例称取药材,进行粉碎成粗,用电子分析天平精确称量药材总质量为16g,用14倍的乙醇进行浸泡20h,再回流提取4h,过滤,取滤液在70℃条件下进行干燥,得到中药药膏,备用;Process: (1) Weigh the medicinal materials according to the prescription ratio, crush them into coarse powder, accurately weigh the total mass of the medicinal materials to be 16 g using an electronic analytical balance, soak them in 14 times ethanol for 20 hours, reflux extract for 4 hours, filter, and dry the filtrate at 70° C. to obtain a Chinese medicine ointment for later use;
(2)精确称量0.70g聚丙烯酸钠、0.60g高岭土和6.5g甘油,混匀作为A相,备用;(2) Accurately weigh 0.70 g of sodium polyacrylate, 0.60 g of kaolin, and 6.5 g of glycerol, mix well as phase A, and set aside;
(3)精确称量0.04g甘氨酸铝、11g酒石酸和0.35g薄荷脑,混匀作为B相,备用;(3) Accurately weigh 0.04 g aluminum glycinate, 11 g tartaric acid, and 0.35 g menthol, mix well as phase B, and set aside;
(4)将A相置于70℃的水浴锅上加热,快速搅拌6min,后把B相加入A相中,继续快速搅拌6min,得到凝胶基质,备用;(4) Heat phase A in a water bath at 70°C and stir rapidly for 6 min. Then add phase B to phase A and continue stirring rapidly for 6 min to obtain a gel matrix for later use.
(5)再将中药药膏加入凝胶基质中,搅拌30min,将得到的膏体平铺在8cm*12cm的无纺布上,放于阴凉处待它冷却凝固,即得凝胶贴膏剂。(5) Add the Chinese medicine ointment to the gel matrix and stir for 30 minutes. Spread the resulting paste on a non-woven fabric of 8 cm*12 cm and place it in a cool place until it cools and solidifies to obtain a gel patch.
用法用量:每12小时用一张凝胶贴膏剂,10天为一个疗程。Dosage and Administration: Use one gel patch every 12 hours, 10 days as a course of treatment.
本发明进行了大量的实验研究,以下为本发明实验研究的结果:The present invention has carried out a lot of experimental studies, and the following are the results of the experimental studies of the present invention:
1工艺研究1. Process Research
1.1提取工艺优化1.1 Extraction process optimization
1.1.1提取工艺优化过程1.1.1 Extraction process optimization
按照处方比例(实施例1处方)称取药材进行粉碎,形成粗粒,用电子分析天平精确称量(药材总质量为17.1g),将药材装放于1000mL烧杯中,用乙醇进行浸泡,浸泡好后装入2000mL圆底烧瓶中。再装入相符的电子调温电热套中,烧瓶口处装配球形回流冷凝管,电热套通电进行加热,保持溶剂煮沸的状态即可,一定时间后取出,通过循环水式多用真空泵、抽滤瓶、滤纸和布氏漏斗趁热抽滤,得到的滤液装入500mL的圆底烧瓶中,不能超出其三分之一,放入旋转蒸发仪中进行旋蒸,去除乙醇和大部分的水,得出最后的液体,将液体装入烧杯,放在电热鼓风干燥箱中,保持70℃,将药物进行烘干,得到药膏,将药膏进行称量,计算出膏率。在此实验设计进程中使用正交试验法做记录和指导,准备9组实验,以乙醇浓度、溶剂用量、回流时间和浸泡时间的4因素做3水平正交试验。设计提取因素如表1:According to the prescription ratio (prescription of embodiment 1), the medicinal material is weighed and crushed to form coarse particles, accurately weighed with an electronic analytical balance (the total mass of the medicinal material is 17.1g), the medicinal material is placed in a 1000mL beaker, soaked with ethanol, and loaded into a 2000mL round-bottomed flask after soaking. Then it is loaded into a corresponding electronic temperature-adjusting electric heating sleeve, a spherical reflux condenser is assembled at the mouth of the flask, and the electric heating sleeve is energized for heating, and the state of keeping the solvent boiling is obtained, and it is taken out after a certain time, and the filtrate is filtered while hot by a circulating water multi-purpose vacuum pump, a suction filtration bottle, filter paper and a Buchner funnel, and the filtrate obtained is loaded into a 500mL round-bottomed flask, and it cannot exceed one-third thereof, and is put into a rotary evaporator for rotary evaporation, and ethanol and most of the water are removed to obtain the final liquid, and the liquid is loaded into a beaker, and placed in an electric heating blast drying oven, and maintained at 70°C, and the medicine is dried to obtain an ointment, and the ointment is weighed, and the ointment rate is calculated. In this experimental design process, the orthogonal test method was used for record and guidance. Nine groups of experiments were prepared, and a three-level orthogonal test was conducted with four factors: ethanol concentration, solvent dosage, reflux time, and soaking time. The designed extraction factors are shown in Table 1:
表1正交因素和水平Table 1 Orthogonal factors and levels
使用正交试验L9(34)进行提取,设计如表2:Orthogonal test L 9 (3 4 ) was used for extraction, and the design is shown in Table 2:
表2中药材提取正交试验Table 2 Orthogonal test of Chinese herbal medicine extraction
1.1.2提取工艺结果1.1.2 Extraction process results
经过9次的实验,得到结果如表3:After 9 experiments, the results are shown in Table 3:
表3正交试验结果Table 3 Orthogonal test results
根据极差R的大小,由直观分析可见,这4种因素对提取效果影响的主次顺序为:乙醇浓度(A)>溶剂用量(B)>回流时间(C)>浸泡时间(D),初步确定最佳提取工艺组合为A1B3C3D2,即在回流提取中乙醇的浓度为60%,溶剂用量为药材的15倍,回流3h,药材要浸泡24h。According to the size of the range R, it can be seen from intuitive analysis that the order of influence of these four factors on the extraction effect is: ethanol concentration (A) > solvent dosage (B) > reflux time (C) > soaking time (D). The optimal extraction process combination is preliminarily determined to be A 1 B 3 C 3 D 2 , that is, in the reflux extraction, the ethanol concentration is 60%, the solvent dosage is 15 times that of the medicinal material, the reflux time is 3 hours, and the medicinal material is soaked for 24 hours.
1.1.3讨论1.1.3 Discussion
在此实验条件中,实验设计涉及3个水平4个因素,在上诉实验结果中我们可以看出,乙醇的浓度取三水平实验中最小的,而且据极差的大小表明,乙醇浓度是影响药材提取率的最大因素,不同的中药材在不同乙醇浓度的提取率不同,但较多的中药材偏向于低浓度乙醇溶液,从实验的结果分析,该处方的中药材因乙醇浓度越低,提取率越高,药物中的有效成分更容易溶于水中;从极差R得知,溶剂用量是影响药物提取率的第二大因素,从溶剂的使用实验结果K分析,随着溶剂使用量的增大,药物的提取率在增加,由此得出溶剂的使用量越大越好;从上表格得知回流时间的长短是药物提取率的第三大影响因素,其K值的表现中,提取率是随着回流时间的加长而变得更高;在四个因素中,虽然浸泡时间的R较小,但也是对药物提取率有着重要的影响,据实验结果表明,药材的浸泡时间在24h为最好,但从K值的结果上看,K1与K2、K3的差距较为明显,而K2和K3数值相差和不大,据此结果表明浸泡时间在24h以上即可。经有研究表明温度、提取时间、粉碎度和溶剂都对提取率有影响,药材有效成分的渗透、溶解、扩散能力随温度升高而增大,溶液的黏度随温度升高而降低,所以提取中加热可加强分子运动,又可软化组织,提高溶解度,从而提高提取率;中草药成分的提取率随提取时间的延长而增加,直至达到平衡为止;药材粉碎越细,则表面积越大,与溶剂接触面积越多,物质出来几率越高,所以提取率就越高;另外,搅拌、提取溶剂的用量等与提取率也有一定关系。In this experimental condition, the experimental design involves 3 levels and 4 factors. From the above experimental results, we can see that the concentration of ethanol is the smallest in the three-level experiment, and the range shows that the concentration of ethanol is the biggest factor affecting the extraction rate of medicinal materials. Different Chinese medicinal materials have different extraction rates at different ethanol concentrations, but more Chinese medicinal materials prefer low-concentration ethanol solutions. From the analysis of the experimental results, the lower the ethanol concentration of the Chinese medicinal materials in this prescription, the higher the extraction rate, and the active ingredients in the medicine are more easily soluble in water; from the range R, we know that the amount of solvent is the second largest factor affecting the extraction rate of the drug. From the analysis of the experimental results K of the use of solvents, As the amount of solvent used increases, the extraction rate of the drug increases, so it can be concluded that the greater the amount of solvent used, the better; from the above table, we can see that the length of the reflux time is the third most important factor affecting the drug extraction rate. In the performance of its K value, the extraction rate becomes higher as the reflux time increases; among the four factors, although the R of the soaking time is relatively small, it also has an important influence on the drug extraction rate. According to the experimental results, the best soaking time for medicinal materials is 24 hours, but from the results of the K value, the gap between K1 and K2 and K3 is more obvious, while the values of K2 and K3 are not much different. Based on this result, it can be seen that the soaking time is more than 24 hours. Studies have shown that temperature, extraction time, degree of grinding and solvent all have an impact on the extraction rate. The penetration, dissolution and diffusion capabilities of the effective ingredients of medicinal materials increase with increasing temperature, and the viscosity of the solution decreases with increasing temperature. Therefore, heating during extraction can enhance molecular movement, soften tissues, and increase solubility, thereby increasing the extraction rate. The extraction rate of Chinese herbal medicine ingredients increases with the extension of extraction time until equilibrium is reached. The finer the medicinal materials are ground, the larger the surface area, the more contact area with the solvent, and the higher the probability of the substance coming out, so the extraction rate is higher. In addition, stirring, the amount of extraction solvent used, etc. also have a certain relationship with the extraction rate.
1.2制剂工艺优化1.2 Formulation process optimization
1.2.1复方痹痛凝胶贴膏的制备1.2.1 Preparation of Compound Bitong Gel Patch
凝胶贴膏由三部分构成,分别是背衬层、防粘层和膏体。背衬层选择无纺布,价格便宜,容易购买;防粘层是膏体的保护层,选择玻璃纸较好;膏体是药材有效成分存在的部位,是决定一整个贴膏质量好坏的关键。膏体由药材有效成分和贴膏基质组成,基质由黏合剂,调节剂,填充剂,保湿剂和透皮促进剂组成。基质选择使用甘氨酸铝、聚丙烯酸钠、甘油、酒石酸、高岭土和薄荷脑。除了薄荷脑以外,其他5种材料均对贴膏成型的质量存在较大的影响,因此选择11g甘油、0.63g聚丙烯酸钠、0.04g甘氨酸铝、0.12g酒石酸和0.65g高岭土作为设定标准线,在这些材料的使用量上下取值,设计多个水平实验,薄荷脑取0.30g。利用常用正交试验表,设计为5因素4水平正交试验,寻找最佳的基质比例搭配。The gel patch is composed of three parts, namely the backing layer, the anti-adhesive layer and the paste. The backing layer is made of non-woven fabric, which is cheap and easy to buy; the anti-adhesive layer is the protective layer of the paste, and cellophane is better; the paste is the part where the active ingredients of the medicinal materials exist, which is the key to determining the quality of the entire patch. The paste is composed of the active ingredients of the medicinal materials and the patch matrix, and the matrix is composed of adhesives, regulators, fillers, moisturizers and transdermal enhancers. The matrix is selected to use aluminum glycinate, sodium polyacrylate, glycerol, tartaric acid, kaolin and menthol. Except for menthol, the other five materials have a great influence on the quality of the patch molding. Therefore, 11g glycerol, 0.63g sodium polyacrylate, 0.04g aluminum glycinate, 0.12g tartaric acid and 0.65g kaolin are selected as the standard line, and the use of these materials is taken above and below, and multiple level experiments are designed, and menthol is taken as 0.30g. Using the commonly used orthogonal test table, a 5-factor 4-level orthogonal test is designed to find the best matrix ratio.
因素水平设计如表4:The factor level design is shown in Table 4:
表4贴膏基质正交试验因素和水平Table 4 Orthogonal test factors and levels of plaster matrix
常用正交表L16(45)设计实验如表5:Commonly used orthogonal table L 16 (4 5 ) design experiments are shown in Table 5:
表5贴膏基质正交试验Table 5 Orthogonal test of plaster matrix
按照实验设计,精确称量聚丙烯酸钠、高岭土和甘油,置于100mL烧杯中,作为A相;精确称量甘氨酸铝,酒石酸和薄荷脑,置于称量纸上,作为B相。将A相置于70℃的水浴锅上加热,快速搅拌7min,后把B相加入A相中,继续快速搅拌7min,将得到的膏体平铺在8cm*12cm的无纺布上,放于阴凉处待它冷却凝固,重复此步骤完成16个实验。According to the experimental design, sodium polyacrylate, kaolin and glycerol were accurately weighed and placed in a 100 mL beaker as phase A; aluminum glycinate, tartaric acid and menthol were accurately weighed and placed on weighing paper as phase B. Phase A was heated in a 70°C water bath and stirred rapidly for 7 minutes, then phase B was added to phase A and continued to stir rapidly for 7 minutes. The resulting paste was spread on a 8cm*12cm non-woven fabric and placed in a cool place until it cooled and solidified. This step was repeated to complete 16 experiments.
待16个实验完成后,依次平铺于阴凉处,静置48h,根据主观评价,对16个成型的贴膏剂进行评分,主要依据贴膏的外观性状、膜残留、皮肤追随性和渗布程度。评价细则如表6:After the 16 experiments were completed, they were spread out in a cool place and left to stand for 48 hours. The 16 formed patches were scored based on subjective evaluation, mainly based on the appearance, film residue, skin follow-up and penetration of the patches. The evaluation details are shown in Table 6:
表6贴膏基质评价标准Table 6 Evaluation criteria for plaster matrix
从实验结果中得到最佳基质用量比例后,加入最佳提取工艺提取出来的药膏,以搅拌时间为因素,测试不同搅拌时间对贴膏的影响,搅拌时间设计为15min、20min和25min,分别对应1、2、3号实验组。在70℃的水浴锅上进行加热搅拌,得到膏体后趁热平铺在8cm*12cm的无纺布上,待其冷却得到成品。将3组实验的贴膏,测试耐热性、初黏力和持粘力对其进行评价。After obtaining the optimal matrix dosage ratio from the experimental results, the ointment extracted by the optimal extraction process was added, and the stirring time was used as a factor to test the effect of different stirring times on the plaster. The stirring time was designed to be 15min, 20min and 25min, corresponding to experimental groups 1, 2 and 3, respectively. The plaster was heated and stirred in a 70°C water bath, and after the paste was obtained, it was spread on a 8cm*12cm non-woven fabric while hot, and the finished product was obtained after it was cooled. The heat resistance, initial adhesion and lasting adhesion of the plasters of the three groups of experiments were tested and evaluated.
1.2.2复方痹痛凝胶贴膏的评价指标1.2.2 Evaluation indicators of Fufang Bitong Gel Patch
(1)外观性状:将得到的成型贴膏剂放在试验台上依次排开,对其外观形状进行主观评价,评价标准则按上诉标准执行。(1) Appearance: Place the obtained molded patches on a test bench and arrange them in order. Subjectively evaluate their appearance. The evaluation criteria shall be in accordance with the above standards.
(2)耐热性:取测试的3片凝胶贴膏,依次放在60℃烘箱中加热2h,待其冷却后,观察其背部的渗布程度,按照上诉有关评价细则,对其进行主观评价,观察膏面的光泽性,用手指轻碰应仍有黏性。(2) Heat resistance: Take three pieces of gel patches to be tested and heat them in a 60°C oven for 2 hours. After they cool down, observe the degree of seepage on the back of the patches. According to the above evaluation criteria, make a subjective evaluation and observe the glossiness of the patch surface. It should still be sticky when touched lightly with a finger.
(3)初黏力的测定:采用斜坡滚硬币停止法测定初粘力,将凝胶贴膏供试品背衬用双面胶固定在地板上,斜坡滑道贴着贴膏背衬边缘,凝胶贴膏黏性面向上,斜坡离地面角度为13°,滑道长40cm,硬币于滑道垂直地面9cm处静止,滚动。滚动的硬币由3枚1元币通过胶水粘连而组成,质量为18g。硬币滚落下来后,用尺子测量硬币在贴膏表面上的滑行距离,判断出贴膏初粘力的优劣。(3) Determination of initial adhesion: The initial adhesion is determined by the ramp rolling coin stopping method. The backing of the gel patch sample is fixed to the floor with double-sided tape. The ramp slide is attached to the edge of the patch backing, with the sticky side of the gel patch facing up. The slope is at an angle of 13° to the ground. The slide is 40 cm long. The coin is stationary and rolls at a position 9 cm above the ground. The rolling coin is composed of three 1-yuan coins bonded together by glue and has a mass of 18 g. After the coin rolls down, use a ruler to measure the sliding distance of the coin on the surface of the patch to determine the quality of the initial adhesion of the patch.
(4)持黏力的测定:将供试品黏性面向上平铺于试验台,下垫硬板,将其背衬层用胶布粘贴于硬板上,使用质量为95g、4cm宽的卷型保鲜膜做为测试工具。将贴膏放平整后,轻轻将卷型保鲜膜放置于贴膏粘性面上,静置1min,后将贴膏进行180°翻转,使卷型保鲜膜置于下方,悬挂在贴膏上,记录其掉落的时间,来判断贴膏的持粘力。(4) Determination of holding force: Lay the sample with the sticky surface facing upward on the test bench, place a hard board underneath, and tape the backing layer to the hard board. Use a 95g, 4cm wide roll of cling film as the test tool. After laying the patch flat, gently place the cling film on the sticky surface of the patch and let it stand for 1 min. Then turn the patch 180° so that the cling film is placed underneath and hung on the patch. Record the time it takes to fall to determine the holding force of the patch.
1.2.3结果1.2.3 Results
基质处方16个实验的主观评分结果如表7:The subjective scoring results of the 16 experiments on matrix prescriptions are shown in Table 7:
表7贴膏基质评价结果Table 7 Evaluation results of plaster matrix
完成16组正交试验,通过主观评分得知,第3、4、11、14和15组实验的外观形状最好,第9组膜残留最好,该实验的皮肤追随性都很不错,粘性可以,第3和4组实验的渗布程度最低,实验效果最好。将感官评分数值代入对应的实验正交表,得如下,计算出其K值和R值,如表8。After completing 16 groups of orthogonal tests, we learned through subjective scoring that the appearance and shape of the experiments in groups 3, 4, 11, 14 and 15 were the best, and the film residue in group 9 was the best. The skin followability of the experiment was very good, the viscosity was acceptable, and the penetration degree of the experiments in groups 3 and 4 was the lowest, and the experimental effect was the best. Substituting the sensory score values into the corresponding experimental orthogonal table, we get the following, and calculate its K value and R value, as shown in Table 8.
表8贴膏基质正交试验结果Table 8 Results of orthogonal test of plaster matrix
从极差R中的比较,直观可见,这5种因素中对基质的影响从大到小为:酒石酸、甘油、聚丙烯酸钠、甘氨酸铝、高岭土。可见高岭土对贴膏基质的影响不大,主要影响到基质质量的是甘油和酒石酸。从实验结果的K值来分析,可以得到贴膏基质制备的最佳工艺为A1B3C3D3E2,即甘油的取量为7g,聚丙烯酸钠为0.63g,甘氨酸铝为0.04g,酒石酸为0.12g和高岭土为0.55g;此外,甘油使用量以减小为佳。From the comparison of the range R, it can be seen intuitively that the influence of these five factors on the matrix from large to small is: tartaric acid, glycerol, sodium polyacrylate, aluminum glycinate, and kaolin. It can be seen that kaolin has little effect on the plaster matrix, and the main factors that affect the quality of the matrix are glycerol and tartaric acid. From the K value of the experimental results, it can be analyzed that the optimal process for preparing the plaster matrix is A 1 B 3 C 3 D 3 E 2 , that is, the amount of glycerol is 7g, sodium polyacrylate is 0.63g, aluminum glycinate is 0.04g, tartaric acid is 0.12g and kaolin is 0.55g; in addition, it is better to reduce the amount of glycerol used.
使用该基质的用量比例,加入药膏后得出的实验结果如表9:The experimental results obtained by using the dosage ratio of the matrix and adding the ointment are shown in Table 9:
表9成型贴膏评价结果Table 9 Evaluation results of molded patches
由实验结果表明,贴膏的外观随着加热搅拌时长的增加而表现的更加均匀,减少气泡和颗粒;耐热性是以渗布情况作为评价标准,从实验结果得知耐热性与贴膏的搅拌时长没有关系;初粘力测试中,随搅拌时长增加,硬币滑行的距离减短;在持粘力试验中,测试工具掉落的时间随搅拌时间加长而变长。The experimental results show that the appearance of the patch becomes more uniform with increasing heating and stirring time, and reduces bubbles and particles; the heat resistance is evaluated based on the penetration of the fabric, and the experimental results show that the heat resistance has nothing to do with the stirring time of the patch; in the initial adhesion test, as the stirring time increases, the sliding distance of the coin decreases; in the sustained adhesion test, the time the test tool falls becomes longer as the stirring time increases.
1.2.4讨论1.2.4 Discussion
在贴膏剂中,基质的配方、比例以及基质材料的挑选是凝胶贴膏剂型优劣的关键,需要进行多次实验进行探究。在实验中可以明显看出,随着甘油用量的增多,膏体的皮肤追随性会减弱,而且渗布程度会增加,甘油多是作为保湿剂的成分,16组实验中得出的K值显示随着甘油用量减少,评分会增高,本实验最佳用量为7g,但是也存在甘油用量越小越好的可能。随着聚丙烯酸钠的用量增多,总评分出现了先升高后降低的走线,由此出现了峰值,按照该比例下,聚丙烯酸钠的用量在0.63g左右为最佳,甘氨酸铝、酒石酸和高岭土与聚丙烯酸钠一样,均出现了峰值,用量也更好确定取值。但是酒石酸的用量对贴膏成型的影响效果较大,有文献指出交联调节剂和Ph调节剂比例相近时膏体有比较好的粘稠度,并且有适中的交联速度,比如甘羟铝和酒石酸的比例相同,所以调整试验,缩进比例,才能保证实验最佳制备工艺。In the patch, the formula, proportion and selection of matrix materials are the key to the quality of the gel patch dosage form, and multiple experiments are needed to explore. It can be clearly seen in the experiment that with the increase in the amount of glycerol, the skin followability of the paste will weaken, and the degree of penetration will increase. Glycerol is mostly used as a moisturizer. The K value obtained in 16 groups of experiments shows that as the amount of glycerol decreases, the score will increase. The optimal amount in this experiment is 7g, but there is also the possibility that the smaller the amount of glycerol, the better. With the increase in the amount of sodium polyacrylate, the total score first increases and then decreases, resulting in a peak. According to this ratio, the amount of sodium polyacrylate is best at about 0.63g. Aluminum glycinate, tartaric acid and kaolin, like sodium polyacrylate, all have peaks, and the amount is easier to determine. However, the dosage of tartaric acid has a greater effect on the formation of the patch. Some literature points out that when the ratio of the cross-linking regulator and the Ph regulator is similar, the paste has a better viscosity and a moderate cross-linking speed. For example, the ratio of aluminum glycolate and tartaric acid is the same. Therefore, adjusting the test and indenting the ratio can ensure the best preparation process of the experiment.
在单因素考察的基础上,用均匀实验设计法,以皮肤追随性、黏附性、赋形性、膜残留作为乳腺宁凝胶膏剂的评价指标,改进基质处方用量,优化的基质处方质量比为甘油:纯水:聚丙烯酸钠:Al(OH)3:酒石酸为0.6475:0.1712:0.1446:0.0163:0.0068。在此实验中显示,甘油的使用量比例为较小。On the basis of single factor investigation, uniform experimental design was used, with skin followability, adhesion, excipient and film residue as evaluation indexes of breast gel ointment, the matrix prescription dosage was improved, and the optimized matrix prescription mass ratio was 0.6475:0.1712:0.1446:0.0163:0.0068 for glycerol:pure water:sodium polyacrylate:Al(OH) 3 :tartaric acid. In this experiment, the usage ratio of glycerol was small.
加热搅拌时长对贴膏也具有极大的影响,实验结果显示加热搅拌的时长越长,外观性状更好,更为均匀,少气泡,少颗粒,而且初粘力和持粘力也随之增加,实验最终结果显示加热搅拌时长越长越好。The heating and stirring time also has a great impact on the patch. The experimental results show that the longer the heating and stirring time, the better the appearance, more uniform, with fewer bubbles and particles, and the initial adhesion and lasting adhesion also increase. The final results of the experiment show that the longer the heating and stirring time, the better.
现有的凝胶贴膏评价指标如感官评价指标,其中包括外观性状、膜残留、皮肤追随性、渗布程度等。虽然存在一定的指导价值,但是因为主观评价差异大,因素多,对实验的成果造成不够严谨和可靠的分析。因此,本实验加入了初黏力和持黏力的客观评价,使实验更有数据可靠性,更加容易得出实验的客观规律。另外,由于甘油用量和搅拌时长对实验的影响没有出现峰值,其还有可探索的余地,需要值得注意,在今后的研究中加以关注。Existing evaluation indicators for gel patches include sensory evaluation indicators, including appearance, film residue, skin follow-up, and penetration. Although they have certain guiding value, the large differences in subjective evaluations and many factors make the analysis of the experimental results less rigorous and reliable. Therefore, this experiment added an objective evaluation of initial adhesion and lasting adhesion to make the experiment more reliable and easier to derive objective laws of the experiment. In addition, since the effects of glycerol dosage and stirring time on the experiment did not reach a peak, there is still room for exploration, which needs to be noted and paid attention to in future research.
1.3含量测定1.3 Content determination
1.3.1供试品溶液制备1.3.1 Preparation of test solution
取提取的药膏3.12g和成型贴膏0.94g,分别置于100mL烧杯中,分别加入15mL和10mL甲醇,置于超声清洗机上超声,充分溶解。Take 3.12 g of the extracted ointment and 0.94 g of the molded patch, put them in 100 mL beakers, add 15 mL and 10 mL of methanol respectively, put them in an ultrasonic cleaner for ultrasonic cleaning, and fully dissolve them.
1.1标准品溶液制备1.1 Preparation of standard solution
取5个10mL干净的量瓶,将5mg齐墩果酸标准品置于第一个量瓶中,加入5mL甲醇,摇匀、溶解,再加甲醇定容至刻度线;从第一个量瓶中取5mL溶液加入到第二个量瓶,定容至刻度线,混合均匀;从第二个量瓶中取5mL溶液加入第三个量瓶中,再加甲醇定容至刻度线,充分混匀;依此继续后面的操作,5个量瓶中都有一定浓度的溶液,1~5号量瓶的溶液浓度分别为0.5mg/mL,0.25mg/mL,0.125mg/mL,0.0625mg/mL和0.03125mg/mL,得到5不同浓度的对照品溶液。Take 5 clean 10mL volumetric bottles, put 5mg oleanolic acid standard in the first volumetric bottle, add 5mL methanol, shake and dissolve, and then add methanol to the scale line; take 5mL of solution from the first volumetric bottle and add it to the second volumetric bottle, make up to the scale line, and mix evenly; take 5mL of solution from the second volumetric bottle and add it to the third volumetric bottle, add methanol to make up to the scale line, and mix thoroughly; continue the subsequent operations in this way, and there are solutions of certain concentrations in the 5 volumetric bottles. The solution concentrations of volumetric bottles 1 to 5 are 0.5mg/mL, 0.25mg/mL, 0.125mg/mL, 0.0625mg/mL and 0.03125mg/mL, respectively, to obtain 5 reference solutions of different concentrations.
1.3.2高效液相法含量测定1.3.2 High performance liquid chromatography assay
(1)进样液制备(1) Preparation of injection solution
用5mL的注射器,取上述供试品和标准品溶液,通过微孔滤膜,过滤后置于高液小瓶中,约1~1.5mL。Use a 5mL syringe to take the above test sample and standard solution, pass it through a microporous filter membrane, filter it and place it in a high-liquid vial, about 1 to 1.5mL.
(2)色谱条件(2) Chromatographic conditions
色谱柱:GH0525046C18A(4.6mm×250mm,5μm);流动相:乙腈:水=90:10;进样量:10μL;柱温:30℃;波长:205nm;流速:1.0mL/min。Chromatographic column: GH0525046C18A (4.6 mm × 250 mm, 5 μm); mobile phase: acetonitrile: water = 90:10; injection volume: 10 μL; column temperature: 30 ° C; wavelength: 205 nm; flow rate: 1.0 mL/min.
1.3.3结果1.3.3 Results
(1)对照品和供试品谱图(1) Spectra of reference and test samples
得到对照品谱图如图4所示,齐墩果酸为图中最大峰,保留时间为10.395min,峰面积为3899.65186mAU*s,齐墩果酸的浓度为0.5mg/mL。The spectrum of the reference substance is shown in FIG4 , in which oleanolic acid is the largest peak, with a retention time of 10.395 min, a peak area of 3899.65186 mAU*s, and a concentration of oleanolic acid of 0.5 mg/mL.
如图5所示,与对照品中相应的保留时间,在供试品1号中,齐墩果酸的保留时间为10.396min,峰面积为838.33606mAU*s。As shown in Figure 5, compared with the corresponding retention time in the reference substance, in test sample No. 1, the retention time of oleanolic acid was 10.396 min, and the peak area was 838.33606 mAU*s.
如图6所示,与对照品中相应的保留时间,在供试品2号中,齐墩果酸的保留时间为10.541min,峰面积为103.32717mAU*s。As shown in Figure 6, compared with the corresponding retention time in the reference substance, in test sample No. 2, the retention time of oleanolic acid was 10.541 min, and the peak area was 103.32717 mAU*s.
(2)数据处理(2) Data processing
对照品的5个不同浓度测高效液相得到的峰面积如表10所示,设计溶液浓度为横坐标,峰面积为纵坐标,结果如图7所示,得齐墩果酸含量的标准曲线。The peak areas of 5 different concentrations of the reference substance measured by HPLC are shown in Table 10, with the designed solution concentration as the abscissa and the peak area as the ordinate. The results are shown in Figure 7, and the standard curve of oleanolic acid content is obtained.
表10高效液相测齐墩果酸标准品结果Table 10 HPLC determination results of oleanolic acid standard
结果得R2=0.9999,则标准曲线的可靠性高,将供试品中对应保留时间的峰面积代入上述得出的标准曲线Y=7764.9X+19.658,计算供试品中齐墩果酸的浓度和含量,结果如表11:As a result, R 2 =0.9999, so the reliability of the standard curve is high. Substitute the peak area of the sample corresponding to the retention time into the standard curve Y=7764.9X+19.658 obtained above to calculate the concentration and content of oleanolic acid in the sample. The results are shown in Table 11:
表11供试品中齐墩果酸含量Table 11 Oleanolic acid content in the test samples
从结果中看出,未制成剂型的药膏中含有齐墩果酸为0.05%,制成剂型后药膏中的齐墩果酸含量为0.03%,由此看出,药膏做成剂型的过程中有一定的损失,但是从损失量上来看,浮动不大,影响较小,做成剂型的药膏可能因不够均匀,或者溶解至甲醇不够完全等的因素,显示齐墩果酸含量比直接提取的药膏低,因此,取其平均值较为准确,以成型的贴膏剂中含有齐墩果酸为药膏的0.04%作为评价标准。From the results, it can be seen that the oleanolic acid content in the unformed ointment is 0.05%, and the oleanolic acid content in the ointment after being formed is 0.03%. It can be seen that there is a certain loss in the process of forming the ointment into a dosage form, but from the perspective of the amount of loss, the fluctuation is not large and the impact is small. The ointment formed into a dosage form may be not uniform enough or not completely dissolved in methanol. The content of oleanolic acid is lower than that of the directly extracted ointment. Therefore, it is more accurate to take the average value and use the oleanolic acid content in the formed patch as 0.04% of the ointment as the evaluation standard.
2.药效学研究2. Pharmacodynamics studies
2.1实验材料2.1 Experimental Materials
2.1.1实验用药2.1.1 Experimental drugs
痹痛方:称取制川乌12g、北细辛6g、苍术9g、独活9g、牛膝9g、全当归12g、穿山龙30g、千年健30g、追地风30g、威灵仙18g、松节15g、红禾麻10g、桑寄生12g、狗脊12g、五加皮12g、鸡血藤15g、三棱12g、莪术12g,经过粉碎形成粗粉,然后用15倍量的60%乙醇浸泡24h,经过回流提取3h后趁热过滤,得到滤液,使用旋转蒸发仪去除滤液中的乙醇等溶剂,最后在烘箱中保持70℃烘干,得到实验所用浸膏。Bitong prescription: weigh 12g of processed Chuanwu, 6g of northern asarum, 9g of Atractylodes, 9g of Angelica dahurica, 9g of Angelica sinensis, 30g of Rhizoma Cynoglossi, 30g of Rhizoma Cibotii, 30g of Rhizoma Cynoglossi, 18g of Clematidis, 15g of Pine knotweed, 10g of Hemp, 12g of Viscum album, 12g of Cibotium bark, 12g of Cortex Acanthopanacis, 15g of Millettia reticulata, 12g of Tripterygium wilfordii, and 12g of Curcuma zedoaria, grind them into coarse powder, then soak them in 15 times the amount of 60% ethanol for 24h, reflux extraction for 3h, then filter them while hot to obtain a filtrate, use a rotary evaporator to remove ethanol and other solvents in the filtrate, and finally dry them in an oven at 70℃ to obtain the extract used in the experiment.
阿司匹林肠溶片,云南白药集团股份有限公司,批号:ZJA2202。规格:25㎎/片,国药准字:H53021845。用法用量:口服,一次2~4片,一日一次。Enteric-coated aspirin tablets, Yunnan Baiyao Group Co., Ltd., batch number: ZJA2202. Specification: 25 mg/tablet, national medicine standard: H53021845. Usage and dosage: Oral, 2 to 4 tablets at a time, once a day.
醋酸泼尼松片,浙江仙据制药股份有限公司,批号:LA22503。规格:5㎎/片,国药准字:H33021207。用法用量:口服,一次1片,一日两次。Prednisone acetate tablets, Zhejiang Xianju Pharmaceutical Co., Ltd., batch number: LA22503. Specification: 5 mg/tablet, national medicine standard: H33021207. Usage and dosage: Oral, 1 tablet at a time, twice a day.
冰醋酸(分析纯),成都金山化学试剂有限公司,批号:20221006,规格:500mL/瓶。Glacial acetic acid (analytical grade), Chengdu Jinshan Chemical Reagent Co., Ltd., batch number: 20221006, specification: 500 mL/bottle.
二甲苯(分析纯),重庆玩盛川东化工有限公司,规格:500mL/瓶。Xylene (analytical grade), Chongqing Wansheng Chuandong Chemical Co., Ltd., specification: 500mL/bottle.
2.1.2实验动物及饲料2.1.2 Experimental animals and feed
SPF级小鼠,体重19-23g,由斯贝福(北京)生物技术有限公司提供,许可证号:SCXK(京)2019-0010。适应性喂养:所有小鼠均在贵州大学药学院实验动物中心适应性喂养3天后使用。SPF mice, weighing 19-23 g, were provided by SPF (Beijing) Biotechnology Co., Ltd., license number: SCXK (Beijing) 2019-0010. Adaptive feeding: All mice were used after 3 days of adaptive feeding at the Experimental Animal Center of the School of Pharmacy of Guizhou University.
饲料及垫料:全价颗粒饲料,玉米芯垫料,均由重庆沃森生物技术有限公司提供。Feed and bedding: Complete pellet feed and corn cob bedding were provided by Chongqing Watson Biotechnology Co., Ltd.
饲养环境:贵州大学药学院501、503SPF级动物房,室内环境整洁、安静,配备由苏州华泰空气过滤器有限公司提供的铝框片式粗效空气过滤器和室内通风系统,湿度30-40%,温度22-25℃。实验动物使用许可证号:SYXK(贵)2022-0004。小鼠分笼饲养,喂全价饲料,自由饮用农夫山泉天然矿泉水。Rearing environment: SPF animal room 501, 503, School of Pharmacy, Guizhou University. The indoor environment is clean and quiet, equipped with aluminum frame sheet coarse air filter and indoor ventilation system provided by Suzhou Huatai Air Filter Co., Ltd., humidity 30-40%, temperature 22-25℃. Laboratory Animal Use License No.: SYXK (Guizhou) 2022-0004. Mice were housed in separate cages, fed with complete feed, and free to drink Nongfu Spring natural mineral water.
2.1.3剂量选择2.1.3 Dose selection
根据受试药(生药)成人临床使用的剂量设定痹痛方高(4倍等效量)、低(等效量)2个剂量组,阳性对照组设立阿司匹林组和醋酸泼尼松组,等效剂量的折算按千克体重剂量折算系数法计算,成人的体重按50kg计算。According to the dose of the test drug (raw drug) used clinically in adults, two dose groups of Bitong Prescription were set: high (4 times the equivalent dose) and low (equivalent dose). Aspirin group and prednisone acetate group were set up as the positive control group. The equivalent dose was calculated using the kilogram body weight dose conversion coefficient method, and the body weight of an adult was calculated as 50 kg.
2.2实验方法2.2 Experimental methods
2.2.1镇痛作用-扭体法2.2.1 Analgesic effect - twisting method
将体重18-22g的SPF级小鼠48只,随机分为醋酸空白组、阿司匹林组(0.72g·kg-1·d-1)、痹痛方低剂量组(1.75g·kg-1·d-1)、痹痛方高剂量组(7g·kg-1·d-1),每组12只。空白组给予等量蒸馏水,实验组分别灌服阿司匹林和不同剂量的痹痛方溶液。一天一次,连续给药7天。于末次给药1.5h后,每只小鼠均腹腔注射0.6%醋酸,0.2mL/只。观察注射醋酸溶液15min后发生扭体反应(腹部收缩内凹、伸展后肢、臀部抬高、蠕行)的次数。使用t检验法比较每个给药组小鼠的扭体次数与未接受治疗的模型组之间是否存在显著性差异,以确定实验结果是否具有统计学意义。Forty-eight SPF mice weighing 18-22g were randomly divided into an acetic acid blank group, an aspirin group (0.72g·kg -1 ·d -1 ), a low-dose Bitong Fang group (1.75g·kg -1 ·d -1 ), and a high-dose Bitong Fang group (7g·kg -1 ·d -1 ), with 12 mice in each group. The blank group was given an equal amount of distilled water, and the experimental groups were given aspirin and different doses of Bitong Fang solution. The administration was once a day for 7 consecutive days. 1.5h after the last administration, each mouse was intraperitoneally injected with 0.6% acetic acid, 0.2mL/mouse. The number of writhing reactions (abdominal contraction and concavity, extension of hind limbs, buttocks lifting, crawling) 15min after the injection of acetic acid solution was observed. The t-test method was used to compare whether there was a significant difference in the number of writhing reactions of mice in each treatment group and the model group that did not receive treatment, so as to determine whether the experimental results were statistically significant.
2.2.2抗炎作用-二甲苯致小鼠耳肿胀法2.2.2 Anti-inflammatory effect - xylene-induced mouse ear swelling method
将体重18-22g的SPF级小鼠48只,随机分为二甲苯空白组、醋酸泼尼松组(0.09g·kg-1·d-1)、痹痛方低剂量组(1.75g·kg-1·d-1)、痹痛方高剂量组(7g·kg-1·d-1),每组12只。空白组给予等量蒸馏水,实验组分别灌服醋酸泼尼松和不同浓度的痹痛方溶液。一天一次,连续给药7天。于末次给药1.5h后,将二甲苯(0.02mL/只)均匀涂抹在小鼠左耳正反面导致炎症。然后25分钟后猝死小鼠,用6mm打孔器在小鼠双耳同一部位打下圆耳片称重。计算左右两耳的重量差异。使用t检验法比较每个给药组小鼠的耳廓肿胀程度与未接受治疗的模型组之间是否存在显著性差异,以确定实验结果是否具有统计学意义。Forty-eight SPF mice weighing 18-22g were randomly divided into a xylene blank group, a prednisone acetate group (0.09g·kg -1 ·d -1 ), a low-dose Bitong Fang group (1.75g·kg -1 ·d -1 ), and a high-dose Bitong Fang group (7g·kg -1 ·d -1 ), with 12 mice in each group. The blank group was given an equal amount of distilled water, and the experimental groups were gavaged with prednisone acetate and Bitong Fang solutions of different concentrations. Once a day, the medication was continued for 7 days. 1.5h after the last administration, xylene (0.02mL/mouse) was evenly applied to the front and back of the left ear of the mouse to cause inflammation. Then, the mouse was killed suddenly 25 minutes later, and a 6mm punch was used to punch a round ear piece at the same part of both ears of the mouse and weigh it. The weight difference between the left and right ears was calculated. The t-test method was used to compare whether there was a significant difference in the degree of ear swelling between each treatment group and the model group that did not receive treatment, in order to determine whether the experimental results were statistically significant.
2.3统计学处理2.3 Statistical analysis
醋酸扭体实验疼痛抑制率计算方法:疼痛抑制率=(空白组扭体反应数-给药组扭体反应数)/空白组扭体反应数×100%。每鼠右耳片重量减去左耳片重即为肿胀度。实验结果用均数±标准差表示,实验数据用SPSS27.0进行统计学分析,组间比较使用单因素ANOVA检验,方差分析用F检验。The calculation method of pain inhibition rate in acetic acid writhing test is as follows: pain inhibition rate = (number of writhing reactions in blank group - number of writhing reactions in drug-treated group) / number of writhing reactions in blank group × 100%. The weight of the right ear piece of each mouse minus the weight of the left ear piece is the swelling degree. The experimental results are expressed as mean ± standard deviation, and the experimental data are statistically analyzed using SPSS27.0. The one-way ANOVA test is used for inter-group comparison, and the F test is used for variance analysis.
2.4结果与讨论2.4 Results and Discussion
2.4.1实验结果2.4.1 Experimental Results
痹痛方对醋酸导致小鼠腹腔扭体次数的影响:阿司匹林组、痹痛方高剂量组小鼠扭体次数明显减少,通过与空白对照组比较,具有统计学意义(p<0.05)。说明痹痛方高剂量组能有效缓解醋酸对小鼠腹腔造成的疼痛,提示痹痛方具有良好的镇痛作用。其中,痹痛方高剂量组镇痛效果明显好于低剂量组。结果见表12。Effect of Bitong Fang on the number of abdominal writhings caused by acetic acid in mice: The number of writhings in the aspirin group and the high-dose Bitong Fang group was significantly reduced, which was statistically significant compared with the blank control group (p < 0.05). This shows that the high-dose Bitong Fang group can effectively relieve the pain caused by acetic acid in the abdominal cavity of mice, indicating that Bitong Fang has a good analgesic effect. Among them, the analgesic effect of the high-dose Bitong Fang group was significantly better than that of the low-dose group. The results are shown in Table 12.
表12痹痛方对醋酸致腹膜炎小鼠扭体次数的影响(n=12,x±s)Table 12 Effect of Bitong Recipe on the number of writhing times of mice with acetic acid-induced peritonitis (n=12, x±s)
注:与空白对照组比较,a p<0.05Note: Compared with the blank control group, a p<0.05
痹痛方对二甲苯导致小鼠耳肿胀程度的影响:实验结果表明,痹痛方低、高剂量组与醋酸泼尼松组对二甲苯致小鼠耳肿胀均有明显的抑制作用,可降低小鼠的耳肿胀,提示痹痛方具有良好的抗炎作用。各给药小组通过与空白对照组比较,具有统计学意义(p<0.05)。其中,痹痛方高剂量组肿胀度明显小于低剂量组,说明高剂量组抗炎效果比低剂量组好。结果见表13。Effect of Bitong Recipe on the degree of ear swelling of mice caused by xylene: The experimental results show that the low-dose and high-dose groups of Bitong Recipe and the prednisone acetate group have a significant inhibitory effect on the ear swelling of mice caused by xylene, and can reduce the ear swelling of mice, indicating that Bitong Recipe has a good anti-inflammatory effect. The comparison between each medication group and the blank control group was statistically significant (p < 0.05). Among them, the swelling degree of the high-dose group of Bitong Recipe was significantly less than that of the low-dose group, indicating that the high-dose group had a better anti-inflammatory effect than the low-dose group. The results are shown in Table 13.
表13痹痛方对二甲苯致小鼠耳肿胀的影响(n=12,x±s)Table 13 Effect of Bitong Recipe on xylene-induced ear swelling in mice (n=12, x±s)
注:与空白对照组比较,ap<0.05Note: Compared with the blank control group, a p<0.05
2.4.2讨论2.4.2 Discussion
乳香含有萜烯类化合物如β-谷烯、α-蒎烯、β-蒎烯等,具有清新、芳香、甜美的气味;没药中含有酚类化合物如没药酚、没药油酚等,使其具有木质、甜美的气味。这两味中药作为复方的香料既可以改善复方的口感和气味,同时也具有活血、舒筋止痛的功效。Frankincense contains terpene compounds such as β-glutene, α-pinene, β-pinene, etc., which have a fresh, aromatic and sweet smell; myrrh contains phenolic compounds such as bisabolol and myrrhol, which give it a woody and sweet smell. These two Chinese medicines as spices in the compound can not only improve the taste and smell of the compound, but also have the effects of promoting blood circulation, relaxing muscles and relieving pain.
川乌具有“祛寒湿风痹、血痹。”(《珍珠囊》),其中含有大量乌头类生物碱,研究表明,乌头类生物碱可以通过影响脊髓小胶质细胞释放强啡肽,使其作用于k-阿片受体产生镇痛作用。独活中含有的香豆素类成分具有共轭双键结构从而含有明显的抗炎、镇痛活性,其中的二氢欧山芹素(二氢欧山芹醇当归酸酯)可以阻断钙通道,且明显抑制由促甲状腺激素激素释放激素诱导产生的催乳素。当归中的挥发油类不仅可以抑制早期炎症的水肿和渗出,还可以抑制炎症晚期组织增生和肉芽组织的形成,具有明显的镇痛抗炎活性。当归的A3活性部位(利用CO2超临界法从当归总挥发油提取得到的中性、非酚性部位)可以明显抑制二甲苯导致的小鼠耳廓肿胀和剂量依赖地抑制由LPS(脂多糖)诱导的大鼠子宫COX-2mRNA和蛋白质表达,表明其镇痛效果可能与其能够抑制COX-2mRNA和蛋白质表达有关。而当归在生活中也常可被用于食材,属于药食同源中药,可以补血活血,调经止痛,因此其提取物亦作为医药和保健行业的产品原料。苍术的主要成分之一β-桉叶醇可以通过阻挡肥大细胞p38丝裂原活化蛋白激酶和NF-kB的活化,抑制受体交互作用蛋白-2表达和半胱天冬酶-1的活化,通过对抗佛波醇酯加钙离子载体A23187人肥大细胞表达IL-6,产生由肥大细胞介导的炎症反应。随着现代科技技术的不断发展,对中药复方的深入研究以及临床验证,将进一步完善中药治疗风湿疾病的体系,并有可能取得更优秀的疗效,减轻患者痛苦,提高患者生活质量。同时,在中西医结合、个性化治疗方面,中药复方将有望成为重要的RA治疗手段之一。Chuanwu has the function of "dispelling cold, dampness, wind and blood stasis." ("Zhenzhu Nang"), which contains a large number of aconite alkaloids. Studies have shown that aconite alkaloids can affect the release of dynorphin by spinal microglia, causing it to act on k-opioid receptors to produce analgesic effects. The coumarin components contained in Duhuo have a conjugated double bond structure and thus have obvious anti-inflammatory and analgesic activities. Dihydro-eugenol (dihydro-eugenol angelic acid ester) can block calcium channels and significantly inhibit the production of prolactin induced by thyrotropin-releasing hormone. The volatile oils in angelica can not only inhibit the edema and exudation of early inflammation, but also inhibit the proliferation of tissues and the formation of granulation tissue in the late stage of inflammation, and have obvious analgesic and anti-inflammatory activities. The A3 active part of Angelica sinensis (a neutral, non-phenolic part extracted from the total volatile oil of Angelica sinensis using the CO2 supercritical method) can significantly inhibit the ear swelling of mice caused by xylene and dose-dependently inhibit the expression of COX-2 mRNA and protein in the rat uterus induced by LPS (lipopolysaccharide), indicating that its analgesic effect may be related to its ability to inhibit the expression of COX-2 mRNA and protein. Angelica sinensis can also be often used as food in life. It is a Chinese medicine with both medicinal and edible properties. It can replenish blood, regulate menstruation and relieve pain. Therefore, its extract is also used as a raw material for products in the pharmaceutical and health care industries. β-eudesminol, one of the main components of Atractylodes lancea, can inhibit the expression of receptor interacting protein-2 and the activation of caspase-1 by blocking the activation of mast cell p38 mitogen-activated protein kinase and NF-kB, and produce an inflammatory response mediated by mast cells by antagonizing the expression of IL-6 by phorbol ester plus calcium ion carrier A23187 human mast cells. With the continuous development of modern science and technology, in-depth research and clinical verification of traditional Chinese medicine compound prescriptions will further improve the system of traditional Chinese medicine treatment of rheumatic diseases, and may achieve better curative effects, alleviate patients' pain, and improve their quality of life. At the same time, in terms of integration of traditional Chinese and Western medicine and personalized treatment, traditional Chinese medicine compound prescriptions are expected to become one of the important RA treatment methods.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311571585.8A CN117338892B (en) | 2023-11-23 | 2023-11-23 | Gel emplastrum for treating arthralgia and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311571585.8A CN117338892B (en) | 2023-11-23 | 2023-11-23 | Gel emplastrum for treating arthralgia and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN117338892A true CN117338892A (en) | 2024-01-05 |
CN117338892B CN117338892B (en) | 2024-11-01 |
Family
ID=89359726
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311571585.8A Active CN117338892B (en) | 2023-11-23 | 2023-11-23 | Gel emplastrum for treating arthralgia and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN117338892B (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1739639A (en) * | 2005-08-30 | 2006-03-01 | 程玉峰 | Obstruction dredging wine |
WO2016058202A1 (en) * | 2014-10-13 | 2016-04-21 | 深圳市前海安测信息技术有限公司 | Traditional chinese medicine composition for treating rheumatic and rheumatoid arthritis and preparation method for same |
CN110433205A (en) * | 2018-05-05 | 2019-11-12 | 四川佳能达攀西药业有限公司 | A kind of monkshood extract gel emplastrum and preparation method thereof |
CN114949163A (en) * | 2022-06-24 | 2022-08-30 | 景立军 | Externally-applied plaster for conditioning shoulder, neck, waist and leg pain and preparation and application methods thereof |
CN115607608A (en) * | 2022-09-09 | 2023-01-17 | 贵州大学 | A kind of compound prickly ash ointment and preparation method thereof |
EP4248953A1 (en) * | 2020-11-20 | 2023-09-27 | Beijing Increasepharm Corporation Limited | Brucine gel plaster and preparation method and use thereof |
-
2023
- 2023-11-23 CN CN202311571585.8A patent/CN117338892B/en active Active
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1739639A (en) * | 2005-08-30 | 2006-03-01 | 程玉峰 | Obstruction dredging wine |
WO2016058202A1 (en) * | 2014-10-13 | 2016-04-21 | 深圳市前海安测信息技术有限公司 | Traditional chinese medicine composition for treating rheumatic and rheumatoid arthritis and preparation method for same |
CN110433205A (en) * | 2018-05-05 | 2019-11-12 | 四川佳能达攀西药业有限公司 | A kind of monkshood extract gel emplastrum and preparation method thereof |
EP4248953A1 (en) * | 2020-11-20 | 2023-09-27 | Beijing Increasepharm Corporation Limited | Brucine gel plaster and preparation method and use thereof |
CN114949163A (en) * | 2022-06-24 | 2022-08-30 | 景立军 | Externally-applied plaster for conditioning shoulder, neck, waist and leg pain and preparation and application methods thereof |
CN115607608A (en) * | 2022-09-09 | 2023-01-17 | 贵州大学 | A kind of compound prickly ash ointment and preparation method thereof |
Non-Patent Citations (3)
Title |
---|
HUANG M, ET AL: "Atractylenolide III inhibits epithelial‑mesenchymal transition in small intestine epithelial cells by activating the AMPK signaling pathway", MOL MED REP, vol. 25, no. 03, 31 March 2022 (2022-03-31), pages 1 - 16 * |
任燕,等: "复方三七吴茱萸滴丸制备方法的优选及其质量标准的初探", 中医临床研究, vol. 07, no. 26, 20 September 2015 (2015-09-20), pages 6 - 9 * |
刘宇宁: "三消饮子联合来氟米特治疗类风湿关节炎的疗效观察", 湖南中医药大学学报, vol. 31, no. 06, 25 June 2011 (2011-06-25), pages 17 - 18 * |
Also Published As
Publication number | Publication date |
---|---|
CN117338892B (en) | 2024-11-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2474314B1 (en) | Antiphlogistic, antioncotic and analgesic chinese herbal composition preparative method and usage thereof | |
CN100542585C (en) | A kind of externally-applied medicinal composition with analgesia and antiinflammatory action | |
WO2014094632A1 (en) | Pharmaceutical composition for treating headache, and preparation method thereof | |
CN102872391A (en) | Chinese medicinal gel for treating gynecological inflammation and preparation method thereof | |
CN102319357B (en) | Lipid-lowering dispersible tablets and preparation technology thereof | |
CN101940621A (en) | Chinese medicinal composition and preparation for relaxing bowel and preparation method thereof | |
CN104435977B (en) | It is a kind of to be used to treat medicine of hepatic injury and preparation method thereof | |
CN117338892B (en) | Gel emplastrum for treating arthralgia and preparation method thereof | |
CN115414435B (en) | Chinese herbal compound Ge Houdan poria cocos granule and preparation method and application thereof | |
CN100450517C (en) | Dysmenorrhea treating Chinese traditional medicine preparation | |
CN102861159B (en) | Medicine composition for treating dysmenorrheal as well as preparation method and application thereof | |
CN106620541B (en) | A kind of external medicine composition for treating chronic eczema and preparation method thereof | |
CN110368445A (en) | A kind of Chinese medicine composition and its preparation method and application for treating psoriasis | |
CN104740557A (en) | Traditional Chinese medicine composition and cream for treating rheumatism and preparation method of traditional Chinese medicine composition and cream | |
CN104398962A (en) | Chinese medicinal composition for treating spleen and kidney deficiency type lumbar muscle degeneration and preparation method thereof | |
CN104474114A (en) | Traditional Chinese medicine composition for treating kidney-yang deficiency type lumbar muscle strain and preparation method of traditional Chinese medicine composition | |
CN107569528A (en) | A kind of pharmaceutical composition for treating hepatitis, pharmaceutical preparation and application and preparation method | |
CN104857363A (en) | Combined Chinese herbal preparation for reducing blood fat and preparation method thereof | |
CN1285372C (en) | Chinese medicine oral preparation for treating gynecologic inflammation and its preparation method | |
CN108125935B (en) | A kind of Lignum Aquilariae Resinatum extract with antiasthmatic effect, prescription and preparation method thereof | |
CN103211873B (en) | Medicinal composition for treating hepatic fibrosis and preparation method thereof | |
CN108186821A (en) | A kind of Chinese medicine composition for treating nervous headache and its preparation method and application | |
CN104000905B (en) | A kind of Chinese medicine for jaundice in pregnancy patient's pruritus vulvae and preparation method thereof | |
CN106267134A (en) | A kind of anti-inflammatory analgesic Chinese medicine composition and preparation method thereof | |
CN117159659A (en) | A traditional Chinese medicine composition for treating eczema and its preparation method and application |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |